SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------------------------------
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
INNOSERV TECHNOLOGIES, INC.
(Name of Issuer)
Common Stock, $.01 Par Value
(Title of Class of Securities)
45765F106
---------
(CUSIP Number)
Robert E. Healing
General Electric Company
3135 Easton Turnpike
Fairfield, CT
(203) 373-2243
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
June 4, 1998
(Date of Event which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the following
box: / /
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 (the "Act") or otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act (however, SEE the
NOTES).
(Continued on following pages)
(Page 1 of 15 Pages)
<PAGE>
SCHEDULE 13D
CUSIP NO. 45765F106 PAGE __OF 15
---------
1 NAME OF REPORTING PERSON
GENERAL ELECTRIC COMPANY, ACTING THROUGH ITS GE MEDICAL SYSTEMS
DIVISION, AND AS THE SOLE SHAREHOLDER OF NATIONAL MEDICAL DIAGNOSTICS,
INC., A DELAWARE CORPORATION
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / /
(b) / /
3 SEC USE ONLY
4 SOURCE OF FUNDS
WC
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) /x/
6 CITIZENSHIP OR PLACE OF ORGANIZATION
NEW YORK
NUMBER OF SHARES 7 SOLE VOTING POWER
BENEFICIALLY OWNED BY
EACH REPORTING PERSON 700,000
WITH
8 SHARED VOTING POWER
0
9 SOLE DISPOSITIVE POWER
700,000
10 SHARED DISPOSITIVE POWER
0
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
700,000
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
/ /
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
18.9%
14 TYPE OF REPORTING PERSON
CO
<PAGE>
ITEM 1. SECURITY AND ISSUER
The class of equity securities to which this Statement relates is the
common stock, par value $.01 per share ("InnoServ Common Stock"), of InnoServ
Technologies, Inc., a California corporation ("InnoServ"), which may be acquired
beneficially by the Reporting Person upon the conversion of InnoServ's Series B
Convertible Preferred Stock, par value $.01 per share (the "InnoServ Preferred
Stock") presently owned by National Medical Diagnostics, Inc., a Delaware
corporation and wholly-owned subsidiary of the Reporting Person ("NMD").
InnoServ's principal executive offices are located at 320 Westway, Suite 520,
Arlington, Texas 76018.
ITEM 2. IDENTITY AND BACKGROUND
This Statement is filed by General Electric Company, a New York
corporation ("GE" or the "Reporting Person"), whose principal business address
is 3135 Easton Turnpike, Fairfield Connecticut 06431-0001. GE and its
consolidated affiliates comprise one of the largest and most diversified
industrial corporations in the world. From the time of its incorporation in
1892, GE has engaged in developing, manufacturing and marketing a wide variety
of products for the generation, transmission, distribution, control and
utilization of electricity. Over the years, development and application of
related and new technologies have broadened considerably the scope of activities
of GE and its affiliates. GE's products include, but are not limited to, lamps
and other lighting products; major appliances for the home; industrial
automation products and components; motors; electrical distribution and control
equipment; locomotives; power generation and delivery products; nuclear
reactors, nuclear power support services and fuel assemblies; commercial and
military aircraft jet engines; materials, including plastics, silicones and
superabrasive industrial diamonds; and a wide variety of high-technology
products, including products used in medical diagnostic applications.
GE also offers a wide variety of services, including product support
services; electrical product supply houses; electrical apparatus installation,
engineering, repair and rebuilding services; and computer-related information
services. The National Broadcasting Company, Inc., a wholly-owned subsidiary, is
engaged principally in furnishing network television services, in operating
television stations, and in providing cable programming and distribution
services in the United States, Europe, and Asia. Through another wholly-owned
subsidiary, General Electric Capital Services, Inc. ("GECS"), and its two
principal subsidiaries, GE offers a broad array of financial services including
consumer financing, commercial and industrial financing, real estate financing,
asset management and leasing, mortgage services, consumer savings and insurance
services, specialty insurance and reinsurance. Other services offered by GECS
include satellite communications furnished by its subsidiary, GE Americom, Inc.
GE also licenses patents and provides technical services related to products it
has developed, but such activities are not material to GE.
<PAGE>
Except as described below, during the past five years, the GE has not
been convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors), nor has it been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of such proceeding
was or is subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, federal or
state securities laws or finding any violation with respect to such laws. In
April, 1994, a U.K. subsidiary of GE, IGE Medical Systems Limited ("IGEMS")
discovered the loss of a radioactive barium source at the Radlett, England
facility. The lost source, used to calibrate nuclear camera detectors, emits a
very low level of radiation. IGEMS immediately reported the loss as required by
the U.K. Radioactive Substances Act. An ensuing investigation, conducted in
cooperation with government authorities, failed to locate the source. On July
21, 1994, Her Majesty's Inspectorate of Pollution ("HMIP") charged IGEMS with
violating the Radioactive Substances Act by failing to comply with a condition
of registration. Such Act provides that a registrant like IGEMS, which "does not
comply with a limitation or condition subject to which (it) is so registered ...
shall be guilty of (a criminal) offense." Condition 7 of IGEMS' registration
states that it "shall so far as is reasonably practicable prevent ... loss of
any registered source."
At the beginning of trial on February 24, 1995, IGEMS entered a guilty
plea and agreed to pay of fine of (pound)5,000 and assessed costs of
(pound)5,754. The prosecutor's presentation focused primarily on the 1991 change
in internal IGEMS procedures and, in particular, the source logging procedure.
The prosecutor complimented IGEMS' investigation and efforts to locate the
source and advised the court that IGEMS had no previous violations of the
Radioactive Substances Act. He also told the court that the Radlett plant had
been highlighted as an exemplary facility to HMIP inspectors as part of their
training. In mitigation, IGEMS emphasized the significant infrastructure and
expense undertaken by IGEMS to provide security for radiation sources and the
significant effort and expense incurred in attempting to locate the missing
source.
The names, principal occupations and business addresses of the
executive officers and directors of GE are set forth in Schedule A attached
hereto, which is incorporated herein by reference. Except as expressly noted in
Schedule A, each such executive officer and director is a citizen of the United
States of America. During the past five years, none of the executive officers or
directors has been convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors), or been a party to a civil proceeding of a
judicial or administrative body of competent jurisdiction and as a result of
such proceeding was or is subject to a judgment, decree or final order enjoining
future violations of, or prohibiting or mandating activities subject to, federal
or state securities laws or finding any violation with respect to such laws.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
GE, through its wholly-owned subsidiary NMD, beneficially acquired
700,000 shares of the InnoServ Preferred Stock (which is, in certain
circumstances, convertible into 700,000 shares of InnoServ Common Stock) for
consideration in the amount of $2,800,000. Such amount was obtained from GE's
working capital.
<PAGE>
ITEM 4. PURPOSE OF TRANSACTION
On May 19, 1998, GE, Diamond Merger Sub, Inc., a California corporation
and a wholly-owned subsidiary of NMD ("Sub"), and InnoServ entered into an
Agreement and Plan of Merger (the "Merger Agreement"), providing for the merger
of Sub with and into InnoServ (the "Merger"), with InnoServ surviving the Merger
and becoming a wholly-owned subsidiary of NMD and an indirect wholly-owned
subsidiary of GE. Pursuant to the Merger Agreement, by virtue of the Merger each
outstanding share of InnoServ Common Stock (other than shares held by InnoServ,
GE or their respective subsidiaries) will be converted into the right to receive
a range of cash consideration between approximately $3.97 to $4.25 per share. In
addition, pursuant to the Merger Agreement, upon consummation of the Merger, the
officers and directors of Sub will replace the existing officers and directors
of InnoServ and the existing bylaws of Sub will become the by-laws of InnoServ.
It is anticipated that, following the consummation of the Merger, the InnoServ
Common Stock will be delisted from the Nasdaq National Market and the InnoServ
Common Stock will be terminated from registration pursuant to Section 12(g)(4)
of the Securities Exchange Act of 1934, as amended. A copy of the Merger
Agreement is included as Exhibit 99 (a) hereto and the description of the Merger
Agreement contained herein is qualified in its entirety by reference to such
exhibit, which is incorporated herein by reference.
Pursuant to the Merger Agreement, in order to induce InnoServ to enter
into the Merger Agreement, GE agreed to purchase, directly or through a
designee, 700,000 shares of InnoServ Preferred Stock; on June 4, 1998 GE's
wholly-owned subsidiary NMD purchased such shares for consideration in the
amount of $2,800,000. Upon consummation of the Merger, GE, through NMD, will
retain beneficial ownership of such InnoServ Preferred Stock. In the event that
the Merger Agreement is terminated and the Merger is not consummated, GE will
evaluate InnoServ's financial condition, operations and prospects and other
business and investment opportunities, economic market conditions and
contractual obligations and in connection with such evaluation (and others which
may occur from time to time) may change its purpose with respect to its
investment and take such actions as it deems appropriate in light of the
circumstances existing at the time. GE may also sell all or a portion of its
InnoServ Preferred Stock, or the InnoServ Common Stock acquired on conversion of
the InnoServ Preferred Stock, in a private placement, public sale or as
otherwise provided pursuant to the terms of the certificate of designation with
respect to the InnoServ Preferred Stock (the "Designation"). A copy of the
Designation is filed as Exhibit 99(b) hereto, and the description of the
InnoServ Preferred Stock contained herein is qualified in its entirety by
reference to such exhibit, which is incorporated herein by reference.
Except as described above, none of the persons named in Item 2 has any
present plan or proposal that relates to or would result in any of the actions
described in clauses (a) through (j) of Item 4 of Schedule 13D.
<PAGE>
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) - (c) GE, through its wholly-owned subsidiary NMD, has the right,
in certain circumstances, to acquire beneficial ownership of 700,000 shares of
InnoServ Common Stock upon the conversion of the InnoServ Preferred Stock,
representing 18.9% of the outstanding shares of such class of stock. Except as
described in this Schedule 13D, neither GE nor, to the best knowledge of GE, any
of the persons listed in Item 2 above beneficially owns any shares of InnoServ
Common Stock. Except as described in this Schedule 13D, neither GE nor, to the
best of its knowledge, any of the persons listed in Item 2 above has effected
any transactions in InnoServ Common Stock during the past 60 days.
(d) When declared by the board of directors of InnoServ out of legally
available funds, GE through NMD, has the right to receive cumulative dividends
on each share of InnoServ Preferred Stock in the amount of $.32. Beginning on
December 6, 1998, such dividends accrue, whether or not earned or declared, and
are due and payable semiannually on the last day of June and December of each
year, beginning on December 31, 1998. Dividends on InnoServ Common Stock may not
be paid or declared unless any accrued but unpaid dividends owed to the holders
of the InnoServ Preferred Stock are paid in full and the outstanding shares of
InnoServ Preferred Stock are included in such dividend PARI PASSU to the shares
of InnoServ Common Stock by assuming conversion of such shares of InnoServ
Preferred Stock into InnoServ Common Stock. As noted in Item 4, a copy of the
Designation is filed as Exhibit 99(b) hereto, and the description of the
InnoServ Preferred Stock contained herein is qualified in its entirety by
reference to such exhibit, which is incorporated herein by reference.
(e) Not applicable
<PAGE>
Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDING OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER.
GE, through its wholly-owned subsidiary NMD, and InnoServ are parties
to a Registration Rights Agreement (the "Registration Rights Agreement")
pursuant to which GE beneficially has the right (with certain limited
exceptions) to participate in registrations of InnoServ's securities under the
Securities Act of 1933, as amended, and the right to demand certain additional
such registrations, with the expenses of such registration to be paid by GE. A
copy of the Registration Rights Agreement is filed as Exhibit 99(c) hereto, and
the description of such agreement contained herein is qualified in its entirety
by reference to such exhibit, which is incorporated herein by reference.
Concurrently with the execution of the Merger Agreement, certain
shareholders (the "Shareholders") of InnoServ possessing sole voting and
dispositive power and/or full voting power as to a total of 1,589,279 shares
(approximately 52.8%) of the outstanding shares of InnoServ Common Stock,
entered into a shareholder agreement (the "Shareholder Agreement") with GE. The
Shareholder Agreement provides, among other things, that: (a) at the
shareholders meeting of InnoServ to be held to approve and adopt the Merger
Agreement (or at any adjournment thereof) or in any other circumstances upon
which a vote, consent or other approval with respect to the Merger or the Merger
Agreement is sought, each Shareholder shall vote (or cause to be voted) the
shares of InnoServ Common Stock owned by such Shareholder as of the date of the
Shareholder Agreement and any other shares of capital stock of InnoServ acquired
by such Shareholder after the date of the Shareholder Agreement and during the
term of the Shareholder Agreement (the "Subject Shares") in favor of the
approval and adoption of the Merger Agreement and the Merger; (b) at any meeting
of shareholders of InnoServ or at any adjournment thereof or in any other
circumstances upon which the Shareholder's vote, consent or other approval is
sought, the Shareholder shall vote (or cause to be voted) the Subject Shares
against (i) any merger (other than the Merger), consolidation, combination, sale
of assets, reorganization, recapitalization, dissolution, liquidation or other
business combination or similar transaction involving InnoServ or its
subsidiaries (including any Business Combination Proposal) (as defined in the
Merger Agreement) which is not approved in writing by GE and (ii) any amendment
to the articles of Incorporation or by-laws of InnoServ or other proposal or
transaction involving InnoServ or any subsidiary, which amendment or other
proposal or transaction would in any manner impede, frustrate, prevent or
nullify the Merger, the Merger Agreement or any of the other transactions
contemplated by the Merger Agreement or which could result in any of the
conditions to InnoServ's obligations under the Merger Agreement not being
fulfilled; and (c) each Shareholder agrees (i) not to sell, pledge, transfer,
tender or dispose of (collectively, "Transfer"), or enter into any contract,
option or other arrangement (including any profit-sharing arrangement) with
respect to the Transfer of the Subject Shares to any person (except to other
Shareholders), (ii) in his capacity as a shareholder of InnoServ, not to take
any action to encourage, solicit or initiate the submission of any Business
Combination Proposal or participate in any way in discussions with or furnish
non-public written information to, any person in connection with any Business
Combination Proposal, (iii) to notify GE of any acquisition of any voting
securities of InnoServ; and (iv) not to enter into any voting arrangement,
whether by proxy, voting agreement or otherwise, inconsistent with the
Shareholder Agreement.
<PAGE>
The obligations of the Shareholders under the Shareholder Agreement
terminate upon the earlier of the close of business on September 30, 1998, the
effective date of the Merger or the termination of the Merger Agreement, except
that if the Merger Agreement is terminated pursuant to certain sections of the
Merger Agreement that may result in a termination fee being paid to GE by
InnoServ, certain obligations set forth in the Shareholder Agreement shall not
terminate until 180 days following the termination.
A copy of the Shareholder Agreement is filed as Exhibit 99(d) hereto,
and the description of the Shareholder Agreement contained herein is qualified
in its entirety by reference to such exhibit, which is incorporated herein by
reference.
As described in Item 4, GE presently anticipates that it will acquire
beneficially the entire equity interest in InnoServ pursuant to the Merger
Agreement. Other than the Merger Agreement described in Item 4, the Designation
described in Item 5 and the Registration Rights Agreement and the Shareholder
Agreement referred to in this Item 6, to the best knowledge of GE, there are no
contracts, arrangements, understandings or relationships (legal or otherwise)
between the persons listed in Item 2 and any person with respect to InnoServ
Common Stock.
Item 7. MATERIAL TO BE FILED AS EXHIBITS.
99(a) Agreement and Plan of Merger dated as of May 19, 1998 among
General Electric Company, Diamond Merger Sub, Inc. and
InnoServ Technologies, Inc.
99(b) Certificate of Designation of Series B Preferred Stock of
InnoServ Technologies, Inc.
99(c) Registration Rights Agreement dated as of June 4, 1998
between National Medical Diagnostics, Inc., and InnoServ
Technologies, Inc.
99(d) Shareholder Agreement dated as of May 19, 1998 between
General Electric Company certain shareholders of InnoServ
Technologies, Inc.
99(e) Power of Attorney for Robert E. Healing and Eliza W. Fraser
dated July 31, 1997.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
GENERAL ELECTRIC COMPANY
Dated: June 11, 1998 By: /S/ ROBERT E. HEALING
---------------------
Robert E. Healing
Corporate Counsel
<PAGE>
EXHIBIT INDEX
-------------
EXHIBIT NO. DESCRIPTION
- ----------- -----------
99(a) Agreement and Plan of Merger dated as of May 19, 1998 among General
Electric Company, Diamond Merger Sub, Inc. and InnoServ Technologies,
Inc.
99(b) Certificate of Designation of Series B Preferred Stock of
InnoServ Technologies, Inc.
99(c) Registration Rights Agreement dated as of June 4, 1998 between
National Medical Diagnostics, Inc., and InnoServ Technologies, Inc.
99(d) Shareholder Agreement dated as of May 19, 1998 between General
Electric Company certain shareholders of InnoServ Technologies, Inc.
99(e) Power of Attorney for Robert E. Healing and Eliza W. Fraser dated July
31, 1997.
<PAGE>
SCHEDULE A
DIRECTORS AND EXECUTIVE OFFICERS OF
GENERAL ELECTRIC COMPANY
The name, business address, title, present principal occupation or
employment of each of the directors and executive officers of GE are set forth
below. If no business address is given, the director's or officer's business
address is GE's address. Unless otherwise indicated, each occupation set forth
opposite an individual's name refers to GE. Unless otherwise indicated below,
all of the persons listed below are citizens of the United States of America.
GENERAL ELECTRIC COMPANY DIRECTORS
<TABLE>
<CAPTION>
NAME PRESENT BUSINESS ADDRESS PRESENT PRINCIPAL OCCUPATION
- ---- ------------------------ ----------------------------
<S> <C> <C>
D.W. Calloway PepsiCo, Inc. Director and Retired
700 Anderson Hill Road Chairman of the Board,
Purchase, NY 10577 Pepsico, Inc.
J.I. Cash, Jr. Harvard Business School Professor of Business
Baker Library 187 Administration-Graduate
Soldiers Field School of Business Administration,
Boston, MA 02163 Harvard University
S.S. Cathcart 222 Wisconsin Avenue Retired Chairman,
Suite 103 Illinois Tool Works
Lake Forest, IL 60045
D.D. Dammerman General Electric Company Senior Vice President--Finance,
3135 Easton Turnpike General Electric Company
Fairfield, CT 06431
P. Fresco General Electric Company Vice Chairman of the
(U.S.A.) Board and Executive Officer,
3 Shortlands, Hammersmith General Electric Company
London, W6 8BX, England
C.X. Gonzalez Kimberly-Clark de Mexico, Chairman of the Board
S.A. de C.V. and Chief Executive Officer,
Jose Luis Lagrange 103, Kimberly-Clark de Mexico,
Tercero Piso S.A. de C.V.
Colonia Los Morales
Mexico, D.F. 11510, Mexico
</TABLE>
<PAGE>
<TABLE>
<S> <C> <C>
G.G. Michelson Federated Department Stores Former Member of the
151 West 34th Street Board of Directors,
New York, NY 10001 Federated Department Stores
E.F. Murphy General Electric Company Vice Chairman of the Board and
3135 Easton Turnpike Executive Officer
Fairfield, CT 064321
S. Nunn King & Spalding Partner, King & Spalding
191 Peachtree Street, N.E.
Atlanta, Georgia 30303
J.D. Opie General Electric Company Vice Chairman of the
3135 Easton Turnpike Board and Executive Officer
Fairfield, CT 06431
R.S. Penske Penske Corporation Chairman of the Board and
13400 Outer Drive, West President,
Detroit, MI 48239-4001 Penske Corporation
F.H.T. Rhodes Cornell University President Emeritus
3104 Snee Building Cornell University
Ithaca, NY 14853
A.C. Sigler Champion International Retired Chairman of the
Corporation Board and CEO and
1 Champion Plaza former Director,
Stamford, CT 06921 Champion International Corporation
D.A. Warner III J. P. Morgan & Co., Inc. Chairman of the Board,
& Morgan Guaranty Trust Co. President, and Chief
60 Wall Street Executive Officer,
New York, NY 10260 J.P. Morgan & Co. Incorporated and
Morgan Guaranty Trust Company
J.F. Welch, Jr. General Electric Company Chairman of the Board
3135 Easton Turnpike and Chief Executive Officer,
Fairfield, CT 06431 General Electric Company
</TABLE>
<PAGE>
Citizenship
-----------
C. X. Gonzalez Mexico
P. Fresco Italy
All Others U.S.A.
GENERAL ELECTRIC COMPANY EXECUTIVE OFFICERS
<TABLE>
<CAPTION>
NAME PRESENT BUSINESS ADDRESS PRESENT PRINCIPAL OCCUPATION
- ---- ------------------------ ----------------------------
<S> <C> <C>
J.F. Welch, Jr. General Electric Company Chairman of the Board and
3135 Easton Turnpike Chief Executive Officer
Fairfield, CT 06431
P. Fresco General Electric Company (U.S.A.) Vice Chairman of the Board
3 Shortlands, Hammersmith Board and Executive Officer
London, W6 8BX, England
P.D. Ameen General Electric Company Vice President and Comptroller
3135 Easton Turnpike
Fairfield, CT 06431
J.R. Bunt General Electric Company Vice President and Treasurer
3135 Easton Turnpike
Fairfield, CT 06431
D.L. Calhoun General Electric Company Senior Vice President - GE Lighting
Nela Park
Cleveland, OH 44122
W.J. Conaty General Electric Company Senior Vice President--Human
3135 Easton Turnpike Resources
Fairfield, CT 06431
D. M. Cote General Electric Company Senior Vice President--GE
3135 Easton Turnpike Appliances
Fairfield, CT 06431
D.D. Dammerman General Electric Company Senior Vice President--Finance
3135 Easton Turnpike
Fairfield, CT 06431
</TABLE>
<PAGE>
<TABLE>
<S> <C> <C>
L.S. Edelheit General Electric Company Senior Vice President--Corporate
P. O. Box 8 Research and Development
Schenectady, NY 12301
B.W. Heineman, Jr. General Electric Company Senior Vice President--General
3135 Easton Turnpike Counsel and Secretary
Fairfield, CT 06431
J. R. Immelt General Electric Company Senior Vice President--GE Medical
P.O. Box 414 Systems
Milwaukee, WI 53201
G. S. Malm General Electric Company Senior Vice President--Asia
3135 Easton Turnpike
Fairfield, CT 06431
W.J. McNerney, Jr. General Electric Company Senior Vice President--GE Aircraft
1 Neumann Way Engines
Cincinnati, OH 05215
E.F. Murphy General Electric Company Vice Chairman of the Board and
3135 Easton Turnpike Executive Officer
Fairfield, CT 06431
R.L. Nardelli General Electric Company Senior Vice President--GE Power
1 River Road Systems
Schenectady, NY 12345
R.W. Nelson General Electric Company Vice President--Corporate Financial
3135 Easton Turnpike Planning and Analysis
Fairfield, CT 06431
J.D. Opie General Electric Company Vice Chairman of the Board
3135 Easton Turnpike and Executive Officer
Fairfield, CT 06431
G.M. Reiner General Electric Company Senior Vice President--Chief
3135 Easton Turnpike Information Officer
Fairfield, CT 06431
</TABLE>
<PAGE>
<TABLE>
<S> <C> <C>
J.G. Rice General Electric Company Vice President - GE Transportation
2901 East Lake Road Systems
Erie, PA 16531
G.L. Rogers General Electric Company Senior Vice President--GE Plastics
1 Plastics Avenue
Pittsfield, MA 01201
J.W. Rogers General Electric Company Vice President--GE Motors
1635 Broadway
Fort Wayne, IN 46801
L.G. Trotter General Electric Company Vice President--GE Electrical
41 Woodford Avenue Distribution and Control
Plainville, CT 06062
</TABLE>
Citizenship
-----------
P. Fresco Italy
G. S. Malm Sweden
All Others U.S.A.
EXHIBIT 99(A)
AGREEMENT AND PLAN
OF MERGER
DATED AS OF
MAY 19, 1998
BY AND AMONG
GENERAL ELECTRIC COMPANY
DIAMOND MERGER SUB, INC.
AND
INNOSERV TECHNOLOGIES, INC.
<PAGE>
TABLE OF CONTENTS
<TABLE>
PAGE
----
<S> <C>
ARTICLE I THE MERGER..............................................................................................1
Section 1.1 THE MERGER..................................................................................1
Section 1.2 EFFECTIVE DATE OF THE MERGER................................................................1
ARTICLE II THE SURVIVING CORPORATION..............................................................................2
Section 2.1 ARTICLES OF INCORPORATION...................................................................2
Section 2.2 BY-LAWS.....................................................................................2
Section 2.3 BOARD OF DIRECTORS AND OFFICERS OF THE SURVIVING CORPORATION................................2
Section 2.4 EFFECTS OF MERGER...........................................................................2
Section 2.5 FURTHER ASSURANCES..........................................................................2
ARTICLE III CONVERSION OF SECURITIES..............................................................................2
Section 3.1 Per Share MERGER CONSIDERATION; CONVERSION AND CANCELLATION OF COMPANY SHARES...............2
Section 3.2 PAYING AGENT AND SURRENDER OF CERTIFICATES..................................................3
Section 3.3 DISSENTING SHARES...........................................................................6
Section 3.4 CONVERSION OF SUB SECURITIES................................................................7
Section 3.5 SHAREHOLDERS TO HAVE NO FURTHER RIGHTS......................................................7
Section 3.6 STOCK OPTIONS...............................................................................7
Section 3.7 MEDIQ PAYMENT...............................................................................8
Section 3.8 ESCROW PAYMENT..............................................................................8
Section 3.9 CLOSING OF THE COMPANY'S TRANSFER BOOKS.....................................................8
Section 3.10 CLOSING....................................................................................8
ARTICLE IV REPRESENTATIONS AND WARRANTIES OF PARENT...............................................................8
Section 4.1 ORGANIZATION AND QUALIFICATION..............................................................8
Section 4.2 AUTHORITY RELATIVE TO THIS AGREEMENT........................................................9
Section 4.3 INFORMATION IN PROXY STATEMENT..............................................................9
Section 4.4 FINANCIAL ADVISOR...........................................................................9
Section 4.5 PARENT NOT AN INTERESTED SHAREHOLDER........................................................9
Section 4.6 FINANCING..................................................................................10
Section 4.7 PARENT ADVERSE EFFECT......................................................................10
ARTICLE V REPRESENTATIONS AND WARRANTIES OF THE COMPANY..........................................................10
Section 5.1 ORGANIZATION AND QUALIFICATION.............................................................10
Section 5.2 CAPITALIZATION.............................................................................10
Section 5.3 AUTHORITY RELATIVE TO THIS AGREEMENT.......................................................11
</TABLE>
<PAGE>
<TABLE>
<S> <C>
Section 5.4 REPORTS AND FINANCIAL STATEMENTS...........................................................12
Section 5.5 ABSENCE OF CERTAIN CHANGES OR EVENTS; LITIGATION...........................................13
Section 5.6 BENEFIT PLANS; EMPLOYEES AND EMPLOYMENT PRACTICES..........................................14
Section 5.7 TAXES......................................................................................16
Section 5.8 ENVIRONMENTAL MATTERS......................................................................17
Section 5.9 INTELLECTUAL PROPERTY MATTERS..............................................................18
Section 5.10 MATERIAL CONTRACTS........................................................................18
Section 5.11 COMPLIANCE WITH LAWS; PERMITS.............................................................18
Section 5.12 TAKEOVER STATUTES.........................................................................18
Section 5.13 FAIRNESS OPINION.........................................................................19
Section 5.14 FINANCIAL ADVISOR.........................................................................19
Section 5.15 INDUSTRY CONDITIONS.......................................................................19
Section 5.16 CUSTOMERS.................................................................................19
Section 5.17 COMPANY MATERIAL ADVERSE EFFECT...........................................................19
Section 5.18 KNOWLEDGE.................................................................................19
ARTICLE VI REPRESENTATIONS AND WARRANTIES REGARDING SUB..........................................................20
Section 6.1 ORGANIZATION...............................................................................20
Section 6.2 CAPITALIZATION.............................................................................20
Section 6.3 AUTHORITY RELATIVE TO THIS AGREEMENT.......................................................20
Section 6.4 SUB ACTION.................................................................................20
Section 6.5 INTERIM OPERATIONS OF SUB..................................................................20
ARTICLE VII CONDUCT OF BUSINESS PENDING THE MERGER...............................................................21
Section 7.1 CONDUCT OF BUSINESS BY THE COMPANY.........................................................21
Section 7.2 REPORTS....................................................................................23
Section 7.3 OBLIGATIONS OF PARENT AND SUB; CONDUCT OF BUSINESS OF SUB..................................24
ARTICLE VIII ADDITIONAL AGREEMENTS...............................................................................24
Section 8.1 ACCESS AND INFORMATION.....................................................................24
Section 8.2 SHAREHOLDERS' MEETING......................................................................24
Section 8.3 PROXY STATEMENT............................................................................25
Section 8.4 EMPLOYEE MATTERS...........................................................................25
Section 8.5 INDEMNIFICATION............................................................................27
Section 8.6 ANTITRUST MATTERS..........................................................................28
Section 8.7 REASONABLE EFFORTS; NOTIFICATION...........................................................28
Section 8.8 NO SOLICITATION............................................................................29
Section 8.9 BONUS PAYMENTS.............................................................................30
Section 8.10 SIDE AGREEMENT............................................................................31
Section 8.11 PREFERRED STOCK DESIGNATION...............................................................31
</TABLE>
<PAGE>
<TABLE>
<S> <C>
ARTICLE IX CONDITIONS PRECEDENT..................................................................................31
Section 9.1 CONDITIONS TO EACH PARTY'S OBLIGATION TO EFFECT THE MERGER.................................31
Section 9.2 CONDITIONS TO OBLIGATION OF THE COMPANY TO EFFECT THE MERGER...............................31
Section 9.3 CONDITIONS TO OBLIGATIONS OF PARENT AND SUB TO EFFECT THE MERGER...........................32
ARTICLE X TERMINATION, AMENDMENT AND WAIVER......................................................................33
Section 10.1 TERMINATION...............................................................................33
Section 10.2 EFFECT OF TERMINATION.....................................................................35
Section 10.3 AMENDMENT.................................................................................35
Section 10.4 WAIVER....................................................................................35
ARTICLE XI GENERAL PROVISIONS....................................................................................35
Section 11.1 NON-SURVIVAL OF REPRESENTATIONS, WARRANTIES AND AGREEMENTS................................35
Section 11.2 NOTICES...................................................................................35
Section 11.3 EXPENSES..................................................................................36
Section 11.4 PUBLICITY.................................................................................37
Section 11.5 INTERPRETATION............................................................................37
Section 11.6 OBLIGATIONS OF PARENT AND OF THE COMPANY..................................................37
Section 11.7 SEVERABILITY..............................................................................37
Section 11.8 MISCELLANEOUS.............................................................................37
</TABLE>
<PAGE>
INDEX OF DEFINED TERMS
PAGE
----
1998 Company Balance Sheet..........................................13
Affected Employees..................................................26
Agreement............................................................1
Business Combination................................................30
Business Combination Proposal.......................................30
Certificate..........................................................3
CGCL.................................................................1
Closing..............................................................8
Closing Date.........................................................8
Code.................................................................5
Commission..........................................................12
Company..............................................................1
Company Common Stock.................................................2
Company Disclosure Schedule.........................................10
Company Financial Advisor...........................................19
Company Holder Agreement.............................................1
Company Licenses....................................................18
Company Material Adverse Effect.....................................19
Company Meeting.....................................................25
Company Preferred Stock.............................................10
Company SEC Reports.................................................12
Company Subsidiaries.................................................3
Company Subsidiary...................................................3
Company Voting Debt.................................................11
Compensation Commitments............................................14
Confidentiality Agreement...........................................24
Constituent Corporations.............................................1
Dissenting Shares....................................................7
Effective Date.......................................................1
Environmental Laws..................................................18
ERISA...............................................................14
ERISA Affiliate.....................................................15
Escrow Agreement.....................................................8
Escrow Payment.......................................................8
Exchange Act.........................................................9
<PAGE>
PAGE
----
Executive Bonus Payments............................................31
FIRPTA..............................................................17
Former Holders.......................................................5
GAAP................................................................12
Governmental Entity.................................................31
Hazardous Material..................................................18
Holder...............................................................3
HSR Act..............................................................9
Indemnified Parties.................................................27
Laws................................................................18
Material Contracts..................................................18
MEDIQ................................................................5
MEDIQ Payment........................................................8
Merger...............................................................1
Merger Consideration.................................................3
Non-ERISA Plans.....................................................14
Order...............................................................31
Outstanding Options..................................................7
Parent...............................................................1
Parent Benefit Plans................................................26
Parent Material Adverse Effect......................................10
Parent Subsidiaries..................................................3
Parent Subsidiary....................................................3
Paying Agent.........................................................3
Pension Plans.......................................................14
Plans...............................................................14
Principal Holders....................................................1
Proxy Statement......................................................9
Puls Agreement.......................................................7
Refund Request.......................................................4
Securities Act......................................................12
Share................................................................2
<PAGE>
PAGE
----
Shareholders' Committee..............................................5
Stock Option Plan....................................................7
Stock Payment Fund...................................................3
Sub..................................................................1
Superior Proposal...................................................30
Surviving Corporation................................................1
Takeover Statute....................................................18
Tax.................................................................16
Tax Return..........................................................16
Tax Sharing Arrangement.............................................16
Taxes...............................................................16
Termination Date....................................................34
Third Party.........................................................29
Welfare Plans.......................................................14
<PAGE>
INDEX OF EXHIBITS
Exhibit A Company Holder Agreement
Exhibit B Outstanding Option Cancellation Agreement
Exhibit C Escrow Agreement
Exhibit D Certain Actions
Exhibit E Executive Bonus Agreements
Exhibit F Side Agreement
Exhibit G Preferred Stock Designation
Exhibit H Opinion of Company's Counsel
<PAGE>
1
AGREEMENT AND PLAN OF MERGER
THIS AGREEMENT AND PLAN OF MERGER (this "AGREEMENT"), dated as of May
19, 1998, by and among General Electric Company, a New York corporation acting
on behalf of its GE Medical Systems business ("PARENT"), Diamond Merger Sub,
Inc., a California corporation and a wholly owned subsidiary of a wholly owned
subsidiary of Parent ("SUB"), and InnoServ Technologies, Inc., a California
corporation (the "COMPANY"). Sub and the Company are sometimes referred to
herein as the "CONSTITUENT CORPORATIONS."
W I T N E S S E T H:
--------------------
WHEREAS, Parent and the Company desire to effect a business combination
by means of the merger of Sub with and into the Company;
WHEREAS, the respective Boards of Directors of Sub and the Company have
approved, and have determined that it is advisable and in the best interests of
their respective shareholders to consummate, the merger of Sub with and into the
Company (the "MERGER"), upon the terms and subject to the conditions set forth
herein;
WHEREAS, concurrently with the execution and delivery of this Agreement
and as an inducement to Parent to enter into this Agreement, certain
shareholders of the Company (the "PRINCIPAL HOLDERS") have entered into an
agreement with Parent, in the form attached hereto as EXHIBIT A (the "COMPANY
HOLDER AGREEMENT"), pursuant to which the Principal Holders have agreed, among
other things, to vote their Shares (as defined in SECTION 3.1) in favor of the
Merger;
NOW, THEREFORE, in consideration of the foregoing premises and the
respective representations, warranties and agreements contained herein, the
parties hereto agree as follows:
ARTICLE I
THE MERGER
Section 1.1 THE MERGER. Upon the terms and subject to the conditions
set forth in this Agreement and in accordance with the California General
Corporation Laws (the "CGCL"), on the Effective Date (as defined in SECTION
1.2), Sub shall be merged with and into the Company and the separate existence
of Sub shall thereupon cease, and the Company, as the surviving corporation in
the Merger (the "SURVIVING CORPORATION"), shall by virtue of the Merger continue
its corporate existence under the laws of the State of California.
Section 1.2 EFFECTIVE DATE OF THE MERGER. The Merger shall become
effective at the date and time (the "EFFECTIVE DATE") when a properly executed
copy of this Agreement and appropriate officers' certificates, in such form as
is required by the CGCL, are duly filed with and accepted by the Secretary of
State of the State of California, which filing shall be made by the Company and
Sub as soon as practicable on the Closing Date (as defined in SECTION 3.10), or
at such time thereafter as is provided in such certificate.
<PAGE>
2
ARTICLE II
THE SURVIVING CORPORATION
Section 2.1 ARTICLES OF INCORPORATION. The Articles of Incorporation of
the Company as in effect on the Effective Date shall be the Articles of
Incorporation of the Surviving Corporation until amended in accordance with the
CGCL.
Section 2.2 BY-LAWS. The By-Laws of Sub as in effect immediately prior
to the Effective Date shall be the By-Laws of the Surviving Corporation until
amended in accordance with the CGCL.
Section 2.3 BOARD OF DIRECTORS AND OFFICERS OF THE SURVIVING
CORPORATION. The directors and officers of Sub immediately prior to the
Effective Date shall be the directors and officers of the Surviving Corporation
until their respective successors shall be duly elected or appointed and
qualified.
Section 2.4 EFFECTS OF MERGER. The Merger shall have the effects set
forth in Section 1107 of the CGCL.
Section 2.5 FURTHER ASSURANCES. If, at any time after the Effective
Date, the Surviving Corporation shall consider or be advised that any deeds,
bills of sales, assignments or assurances or any other acts or things are
necessary, desirable or proper to vest, perfect or confirm, of record or
otherwise, in the Surviving Corporation its rights, title and interest in, to or
under any of the rights, privileges, powers, franchises, properties or assets of
either of the Constituent Corporations, the Surviving Corporation and its proper
officers and directors or their designees shall be authorized to execute and
deliver, in the name and on behalf of either Constituent Corporation, all such
deeds, bills of sale, assignments and assurances and to do, in the name and on
behalf of either Constituent Corporation, all such other acts and things as may
be necessary, desirable or proper to vest, perfect or confirm the Surviving
Corporation's right, title and interest in, to and under any of the rights,
privileges, powers, franchises, properties or assets of such Constituent
Corporation.
ARTICLE III
CONVERSION OF SECURITIES
Section 3.1 PER SHARE MERGER CONSIDERATION; CONVERSION AND CANCELLATION
OF COMPANY SHARES. At the Effective Date, by virtue of the Merger and without
any action on the part of Parent, Sub, the Company or their respective
shareholders (other than the filing of the documents referred to in SECTION 1.2
hereof):
(a) each share (a "SHARE") of common stock, par value $0.01 per share,
of the Company ("COMPANY COMMON STOCK") issued and outstanding
immediately prior to the Effective Date (other than (i) Shares held by
Parent or Sub, (ii) Shares held by any corporation, partnership, joint
venture, or other entity in which the Company (A) owns directly or
indirectly, 50% or more of the outstanding voting securities or equity
interests other than the Shares held by the InnoServ Technologies, Inc.
<PAGE>
3
Employee Stock Purchase Plan or (B) is a general partner (individually,
a "COMPANY SUBSIDIARY," and collectively, the "COMPANY SUBSIDIARIES"),
(iii) Shares held by any corporation, partnership, joint venture or
other entity in which Parent (A) owns, directly or indirectly, 50% or
more of the outstanding voting securities or equity interests or (B) is
a general partner (individually, a "PARENT SUBSIDIARY," and
collectively, the "PARENT SUBSIDIARIES"), and (iv) Dissenting Shares
(as defined in SECTION 3.3) in respect of which appraisal rights are
properly exercised and perfected) shall be converted into (i) the right
to receive, in cash, an amount equal to (A) the remainder of (I)
$16,000,000 minus (II) (a) the MEDIQ Payment (as defined in SECTION
3.7), and (b) the Escrow Payment (as defined in SECTION 3.8), DIVIDED
by (B) the number of shares outstanding as of the Effective Date,
without interest thereon (the "PER SHARE MERGER CONSIDERATION") and
(ii) the contingent right to receive additional consideration pursuant
to the Escrow Agreement (as defined in SECTION 3.8). The Per Share
Merger Consideration shall be payable upon surrender of the certificate
previously representing such Share (a "CERTIFICATE") in the manner
provided in SECTION 3.2.
(b) each Share then owned by any Company Subsidiary shall be
canceled without conversion and without payment of consideration and
shall cease to exist; and
(c) each Share owned beneficially or of record by Parent, Sub
or any other Parent Subsidiary immediately prior to the Effective Date
shall be canceled without conversion and without payment of
consideration and shall cease to exist.
Section 3.2 PAYING AGENT AND SURRENDER OF CERTIFICATES.
(a) Prior to the Effective Date, the Company and Parent shall
appoint The Bank of New York or such other bank or trust company
selected by Parent and reasonably acceptable to the Company, and having
a place of business in New York City, as paying agent (the "PAYING
AGENT") for purposes of this Agreement.
(b) Immediately after the Effective Date, Parent shall cause
the Surviving Corporation to deposit with the Paying Agent, for the
benefit of the persons entitled to payment hereunder, funds equal to
the remainder of (A) $16,000,000 MINUS (B) (I) the MEDIQ Payment, and
(II) the Escrow Payment (the "STOCK PAYMENT FUND"). The Paying Agent
shall invest the Stock Payment Fund as Parent directs, in direct
obligations of the United States of America, obligations for which the
full faith and credit of the United States of America is pledged to
provide for the payment of all principal and interest, commercial paper
obligations receiving the highest rating from either Moody's Investors
Services, Inc. or Standard & Poor's Corporation, or certificates of
deposit, bank repurchase agreements or banker's acceptances of
commercial banks with capital exceeding $25,000,000,000. The Stock
Payment Fund shall not be used for any other purpose except as provided
in this Agreement.
(c) On or as soon as practicable after the Effective Date, the
Surviving Corporation shall cause the Paying Agent to mail to each
person who was a record holder of Company Common Stock at the Effective
Date (individually, a "HOLDER" and collectively, the "HOLDERS") (other
<PAGE>
4
than Parent, Sub, the Company, Parent Subsidiaries or Company
Subsidiaries), a form of letter of transmittal (which shall specify
that delivery shall be effected, and risk of loss and title to the
Certificates shall pass, only upon proper delivery of the Certificates
to the Paying Agent and shall otherwise be in such form and have such
provisions as Parent and the Company may reasonably specify) and
instructions for use in effecting the surrender for payment of
Certificates that immediately prior to the Effective Date represented
Company Common Stock. Upon surrender of a Certificate to the Paying
Agent, together with a duly executed letter of transmittal, the holder
of the Certificate shall be entitled to receive immediately, in
exchange therefor cash in an amount equal to the product of the number
of Shares previously represented by such Certificate or Certificates
surrendered and the Per Share Merger Consideration.
No interest will be paid or accrued on the cash payable upon the
surrender of the Certificates. If a payment is to be made to a person
other than the person in whose name a surrendered Certificate is
registered, it shall be a condition of payment that (x) the Certificate
so surrendered shall be properly endorsed or otherwise in proper form
for transfer and that (y) the person requesting such payment shall pay
any transfer or other taxes required by reason of the payment to a
person other than the registered holder of the Certificate surrendered
or establish to the satisfaction of Parent or the Paying Agent that
such tax has been paid or is not applicable. After the Effective Date,
until surrendered in accordance with the provisions of this SECTION
3.2, a Certificate shall represent only the right to receive the Per
Share Merger Consideration in cash multiplied by the number of Shares
previously evidenced by such Certificate, without any interest thereon
and the contingent right to receive additional consideration pursuant
to the Escrow Agreement.
(d) On or after the one hundred eightieth day following the
Effective Date, the Surviving Corporation may by written request
require the Paying Agent to remit to the Surviving Corporation (on
terms reasonably satisfactory to the Paying Agent) (a "REFUND REQUEST")
any funds held in the Stock Payment Fund that (i) have not been applied
prior to any such Refund Request to make payments in respect of
Certificates or (ii) are not required at the time of such Refund
Request to permit the Paying Agent to make payment to the holders of
any Certificates that have been surrendered by the date of such Refund
Request for which payment is pending, but with respect to which no such
payment has yet been made at the time of such Refund Request. Any
holders of Shares who have not theretofore complied with Section 3.2(c)
shall thereafter look only to the Surviving Corporation (subject to
abandoned property, escheat or other similar laws) for payment of their
claim for the Per Share Merger Consideration, without any interest
thereon, but shall have no greater rights against the Surviving
Corporation than may be accorded to general creditors of the Surviving
Corporation under California law.
(e) The Surviving Corporation shall pay all charges and
expenses, including those of the Paying Agent, in connection with the
exchange of cash for the Shares.
<PAGE>
5
(f) Neither Parent, Sub nor the Company shall be liable to any
holder of Shares for any Per Share Merger Consideration delivered to a
public official pursuant to any applicable abandoned property, escheat
or similar law.
(g) The Paying Agent and Surviving Corporation shall be
entitled to deduct and withhold from the Per Share Merger Consideration
otherwise payable pursuant to this Agreement to any holder of Shares
such amounts as the Paying Agent or Surviving Corporation is required
to deduct and withhold with respect to the making of such payment under
the Internal Revenue Code of 1986, as amended (the "CODE"), or any
provision of state, local or foreign tax law. To the extent that
amounts are so withheld by the Paying Agent or Surviving Corporation,
such withheld amounts shall be treated for all purposes of this
Agreement as having been paid to the holder of the Shares in respect of
which such deduction and withholding was made by the Paying Agent or
Surviving Corporation.
(h) In the event any Certificates shall have been lost, stolen
or destroyed, the Paying Agent shall deliver in exchange for such lost,
stolen or destroyed Certificates the Per Share Merger Consideration as
may be required pursuant to SECTION 3.2 upon (i) the making of an
affidavit of that fact by the holder thereof, and (ii) if required by
Parent, the posting by such person of a bond in customary amount as
indemnity against any claim that may be made against it with respect to
such Certificate.
(i) Effective as of the date hereof, the Shareholders' Committee
(the "SHAREHOLDERS' COMMITTEE") will be constituted and will be
composed of Michael Puls, President and Chief Executive Officer of the
Company, Dudley Rauch, Chairman of the Board of the Company and a
third Holder to be appointed by Mr. Puls and Mr. Rauch, each of whom
has agreed to serve as a member of the Shareholders' Committee. The
Shareholders' Committee will continue in existence until all of its
duties under this Agreement and the Escrow Agreement are discharged.
(ii) The Shareholders' Committee will have full and irrevocable
power and authority to act for and in the name of, and as the agent
for, the Holders and the holders of Outstanding Options (as defined in
SECTION 3.6) (collectively, the "FORMER HOLDERS") without giving
notice to the Former Holders or obtaining their consent, in connection
with all matters relating to the Escrow Payment and to enforce,
pursue, compromise, settle and waive the rights of the Former Holders
relating to the Escrow Payment, subject to the specific limitations
set forth below, and to do all such things and execute all such
instruments as it deems necessary, proper or desirable in order to
promote the interests of the Former Holders, including, without
limitation, to settle any dispute with MEDIQ Incorporated ("MEDIQ")
relating to the Escrow Agreement; provided that in no event will the
Shareholders' Committee have the power or authority to settle any
dispute among the Holders with respect to their individual proportion
of the Escrow Payment as disbursed by the Escrow Agent (as defined in
the Escrow Agreement), if any, to be received by any Former Holder.
<PAGE>
6
Any determination as to what is in the interests of the Former Holders
made by the Shareholders' Committee in good faith will be conclusive
and binding on all Former Holders and their successors and assigns.
(iii) The Shareholders' Committee (A) may rely on any document
believed by it to be genuine and to have been signed or presented by
the proper person, (B) need not investigate any fact or matter stated
in such document, and (C) may act through its attorneys and agents and
will not be responsible for the misconduct or negligence of any agent
appointed with due care. The Shareholders' Committee may consult with
counsel and the advice or opinion of such counsel as to matters of law
will be full and complete authorization and protection in respect of
any action taken, omitted, or suffered by it under this Agreement in
good faith and in accordance with the advice or opinion of such
counsel.
(iv) Any action to be taken by the Shareholders' Committee may be
taken by a majority of its members present at a meeting of the
Shareholders' Committee (a quorum being present), including any
meeting held by means of conference telephone or similar
communications equipment by means of which all persons participating
in the meeting can hear each other, or by written consents of all
members of the Shareholders' Committee. If a member of the
Shareholders' Committee resigns, dies, or becomes incapacitated, the
remaining members of the Shareholders' Committee will appoint a
successor member, notwithstanding the absence of a quorum. If all
three positions on the Shareholders' Committee become simultaneously
vacant, successors may be appointed by the written action of the
Former Holders of a majority of the shares of Company Common Stock and
the Outstanding Options as of the Effective Date, except that if such
vacancy results from the simultaneous resignation of members of the
Shareholders' Committee, the resigning member(s) may appoint
successors. The number of members of the Shareholders' Committee will
be three. Unless he resigns, each member of the Shareholders'
Committee will serve until the duties of the Shareholders' Committee
have been fully discharged. At any meetings of the Shareholders'
Committee, two members will constitute a quorum.
(v) The Shareholders' Committee and its members will not be
liable for any action they take or omit to take in good faith that
they believe to be authorized or within their rights or powers. All
out-of-pocket expenses reasonably incurred on or after the Effective
Date by the Shareholders' Committee (including attorneys' and
professionals' fees) in discharging the duties of the Shareholders'
Committee under this Agreement will be paid out of the Escrow Payment
pursuant to the terms of the Escrow Agreement. The Surviving
Corporation shall indemnify, defend and hold harmless each member of
the Shareholders' Committee (and their respective successors, assigns,
<PAGE>
7
heirs, executors, administrators and representatives) against any and
all costs, expenses, claims, damages or liabilities arising out of or
based upon any action or inaction of the Shareholders' Committee under
or in connection with this Agreement or the Escrow Agreement.
Section 3.3 DISSENTING SHARES. Notwithstanding anything in this
Agreement to the contrary, Shares which are issued and outstanding immediately
prior to the Effective Date and which are held by shareholders who have properly
exercised appraisal rights with respect thereto under Section 1301 of the CGCL
(the "DISSENTING SHARES") shall not be converted into the right to receive the
Per Share Merger Consideration as provided in SECTION 3.1, but the holders of
Dissenting Shares shall be entitled to receive such payment as shall be
determined pursuant to Chapter 13 of the CGCL; provided, that if any such holder
shall have failed to perfect or shall withdraw or lose the right to appraisal
and payment under the CGCL, then such holder shall forfeit the right of dissent
and each such holder's Shares shall thereupon be deemed to have been converted
as of the Effective Date into the right to receive the Per Share Merger
Consideration, without any interest thereon, as provided in SECTION 3.1, and
such Shares shall no longer be Dissenting Shares. The Company shall give Parent
prompt notice of any demands for payment under Section 1301 of the CGCL received
by the Company. Except as required by applicable law, prior to the Effective
Date, the Company shall not, except with the prior written consent of Parent,
make any payment with respect to, or settle or offer to settle, any such
demands.
Section 3.4 CONVERSION OF SUB SECURITIES. At the Effective Date, each
share of common stock, par value $0.01 per share, of Sub issued and outstanding
immediately prior to the Effective Date shall be converted, by virtue of the
Merger and without any action on the part of the holder thereof, into one fully
paid and nonassessable share of the common stock, par value $0.01 per share, of
the Surviving Corporation.
Section 3.5 SHAREHOLDERS TO HAVE NO FURTHER RIGHTS. At and after the
Effective Date, the holder of a Certificate shall cease to have any rights as a
shareholder of the Company, except for (i) the right to surrender such
Certificate in exchange for the amount of Per Share Merger Consideration and the
contingent right to receive additional consideration pursuant to the Escrow
Agreement to which such holder is entitled under this Agreement and (ii) the
rights available under the CGCL for Dissenting Shares. In no event shall the
holder of a Certificate have any rights as a shareholder of the Surviving
Corporation.
Section 3.6 STOCK OPTIONS. At the Effective Date, each of the options
to purchase Company Common Stock granted under (i) the Company's 1992 Stock
Incentive Plan, as amended (the "STOCK OPTION PLAN") that is outstanding as of
the Effective Date and (ii) the Stock Option Agreement dated as of December 11,
1996 between the Company and Michael G. Puls (the "PULS AGREEMENT," and
collectively with the options outstanding under the Stock Option Plan, the
"OUTSTANDING OPTIONS"), whether or not then vested, exercisable or effective,
shall, by action of the Board of Directors of the Company or a duly authorized
Committee thereof, under the terms of the Stock Option Plan and the agreements
evidencing the options granted thereunder or the Puls Agreement, as applicable,
and without any action on the part of the holder thereof, vest and become
effective and exercisable solely for the Per Share Merger Consideration (without
interest). Prior to the Effective Date, each holder of Outstanding Options shall
<PAGE>
8
be offered the right to execute an agreement, substantially in the form attached
hereto as Exhibit B, to cancel such Outstanding Options. Immediately after the
Effective Date and in no event later than the first payment to a Holder pursuant
to SECTION 3.2, Parent shall cause the Surviving Corporation to pay to each
holder of an Outstanding Option who executes such an agreement, in consideration
for such cancellation, an amount in cash (less applicable withholding taxes, if
any) equal to the amount and in the manner set forth in the agreement attached
hereto as Exhibit B; provided that if such amount is equal to or less than zero,
such Outstanding Option shall be deemed canceled and terminated. For purposes of
this SECTION 3.6, each of the Company, Sub and Parent agree that each option
listed on SECTION 5.2 of the Company's Disclosure Schedule (as hereinafter
defined), unless such option is exercised or expires in accordance with the
provisions of Stock Option Plan or Puls Agreement prior to the Effective Date,
is an Outstanding Option.
Section 3.7 MEDIQ PAYMENT. Immediately after the Effective Date, and in
no event later than the first payment to a Holder pursuant to SECTION 3.2, the
Parent shall cause the Surviving Corporation to pay to MEDIQ in cash, without
interest thereon and less applicable withholding taxes, if any, by wire transfer
to an account designated by MEDIQ an amount equal to $3,218,997 (the "MEDIQ
Payment.")
Section 3.8 Escrow Payment. Immediately after the Effective Date,
Parent shall cause the Surviving Corporation to deposit with the Paying Agent,
an amount, in cash, equal to $833,879 (the "Escrow Payment"), to be disbursed by
the Paying Agent pursuant to the terms and conditions of the escrow agreement
attached hereto as Exhibit C (the "Escrow Agreement"). In the event that the
parties to the Escrow Agreement shall provide written notice to the Parent, duly
executed by each such party prior to the Effective Date that such parties have
reached agreement with respect to the disbursement of the Escrow Payment, the
Company, Parent and Sub each hereby agrees to amend this Agreement to reflect
such agreement.
Section 3.9 CLOSING OF THE COMPANY'S TRANSFER BOOKS. After the close of
business on the Effective Date, the stock transfer books of the Company shall be
closed and no transfer of Shares shall be made thereafter. In the event that,
after the Effective Date, Certificates are presented to the Surviving
Corporation, they shall be forwarded to the Paying Agent and be subject to the
provisions of SECTION 3.2.
Section 3.10 CLOSING. Unless this Agreement is terminated and the
transactions contemplated herein abandoned pursuant to SECTION 10.1, and subject
to the satisfaction or, if permissible, waiver of the conditions set forth in
ARTICLE IX, the consummation of the Merger and the closing of the transactions
contemplated by this Agreement (the "CLOSING") shall take place (i) at the
offices of Gibson, Dunn & Crutcher, 1717 Main Street, Suite 5400, Dallas, Texas,
at 9:00 A.M. local time on a date to be specified by Parent and the Company, but
as soon as practicable (and in any event within two business days) after the day
on which the last of the conditions set forth in ARTICLE IX is fulfilled or, if
permissible, waived or (ii) at such other time and place as Parent and the
Company shall agree in writing. The date on which the Closing occurs is referred
to herein as the "CLOSING DATE."
<PAGE>
9
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF PARENT
Parent represents and warrants to the Company as follows:
Section 4.1 ORGANIZATION AND QUALIFICATION. Parent is a corporation
duly organized, validly existing and in good standing under the laws of the
State of New York and has all requisite corporate power and authority to own and
operate its properties and assets and to carry on its business as it is now
being conducted. Parent is duly qualified as a foreign corporation, and is in
good standing, in each jurisdiction where the character of its properties owned
or held under lease or the nature of its activities make such qualification
necessary, except where the failure to be so qualified and in good standing will
not have a Parent Material Adverse Effect (as defined in SECTION 4.7).
Section 4.2 AUTHORITY RELATIVE TO THIS AGREEMENT. Parent has the
requisite corporate power and authority to enter into this Agreement and to
carry out its obligations hereunder and to consummate the transactions
contemplated hereby. The execution, delivery and performance of this Agreement
by Parent and the consummation of the transactions contemplated hereby by Parent
have been duly authorized by all necessary corporate action on the part of
Parent. This Agreement has been duly executed by Parent and constitutes a valid
and binding obligation of Parent enforceable in accordance with its terms except
as enforcement may be limited by bankruptcy, insolvency or other laws affecting
the enforcement of creditors' rights generally. Neither the execution and
delivery of this Agreement nor the consummation of the transactions contemplated
hereby will (a) conflict with or violate the charter or by-laws of Parent or (b)
result in any breach or constitute a default (with or without notice or lapse of
time, or both) or give rise in others to any rights of termination, cancellation
or acceleration under any agreement, indenture, contract, loan agreement,
license, franchise, permit, order, decree, concession, lease, instrument,
judgment, statute, law, ordinance, rule or regulation applicable to Parent or
any Parent Subsidiary or its or their respective assets, other than, in the case
of clause (b) only, breaches, defaults, violations and losses of rights that
would not have a Parent Material Adverse Effect and the laws and regulations
referred to in the next sentence. Except in connection, or in compliance, with
the provisions of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended (which filing has been made) (the "HSR ACT"), the Securities Exchange
Act of 1934, as amended (the "EXCHANGE ACT"), and the corporation, securities or
blue sky laws or regulations of the various states, no filing or registration
with, or authorization, consent or approval of, any governmental or regulatory
body or authority is necessary for the consummation by Parent of the Merger or
the other transactions contemplated by this Agreement, except where the failure
to make any such filing or registration or obtain any such authorization,
consent or approval would not have a Parent Material Adverse Effect or prevent
or materially delay consummation of the Merger.
Section 4.3 INFORMATION IN PROXY STATEMENT. None of the information
supplied by Parent or Sub to be included or incorporated by reference in the
proxy statement of the Company (the "PROXY STATEMENT") required to be mailed to
the shareholders of the Company in connection with the Merger will at the time
<PAGE>
10
of the mailing of the Proxy Statement and any amendments or supplements thereto,
and at the time of the Company Meeting (as defined in SECTION 8.2) to be held in
connection with the Merger, contain any untrue statement of a material fact or
omit to state any material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances under which
they are made, not misleading.
Section 4.4 FINANCIAL ADVISOR. No broker, finder or investment banker
is entitled to any brokerage, finder's or other fee or commission in connection
with the Merger or the transactions contemplated by this Agreement based upon
arrangements made by or on behalf of Parent.
Section 4.5 PARENT NOT AN INTERESTED SHAREHOLDER. Neither Parent nor any of
its affiliates is an "Interested Party" pursuant to Section 1203 of CGCL.
Section 4.6 FINANCING. Parent and Sub have available to them funds
necessary to satisfy their respective obligations hereunder.
Section 4.7. PARENT ADVERSE EFFECT. For purposes of this Agreement,
"PARENT MATERIAL ADVERSE EFFECT" means any change, effect, circumstance or event
that is materially adverse to the business, operations or financial condition of
Parent and the Parent Subsidiaries taken as a whole, other than changes,
effects, circumstances or events: (i) affecting Parent's industry generally,
(ii) resulting from general economic conditions, or (iii) resulting from the
transactions contemplated by this Agreement or the announcement thereof.
ARTICLE V
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
The Company represents and warrants to Parent and Sub that, except as
set forth in the disclosure schedule delivered by the Company to Parent and Sub
on the date of this Agreement (the "COMPANY DISCLOSURE SCHEDULE") (it being
understood that disclosure of any items, facts, circumstances or the like as an
exception with respect to a representation, warranty or covenant of the Company
in the Company Disclosure Schedule with reference to a particular section of
this Agreement shall be deemed to be disclosed, and an exception with respect to
all representations, warranties and covenants of the Company, if a reasonable
person knowledgeable of the Company's industry would determine, in light of the
level and particularity of the disclosure, that such disclosure is relevant or
an exception would be applicable):
Section 5.1 ORGANIZATION AND QUALIFICATION. The Company is a
corporation duly organized, validly existing and in good standing under the laws
of the State of California. Each Company Subsidiary is a corporation duly
organized, validly existing and in good standing under the laws of the
jurisdiction set forth opposite its name on SECTION 5.1 of the Company
Disclosure Schedule. Each of the Company and the Company Subsidiaries has all
requisite corporate power and authority to own and operate its properties and
assets and to carry on its business as it is now being conducted. Each of the
Company and the Company Subsidiaries is duly qualified as a foreign corporation,
and is in good standing, in each jurisdiction where the character of its
properties owned or held under lease or the nature of its activities makes such
qualification necessary, except where the failure to be so qualified or in good
standing will not have a Company Material Adverse Effect. Complete and correct
copies as of the date hereof of the charter and by-laws or comparable
<PAGE>
11
organizational documents of the Company and each of the Company Subsidiaries
have been delivered to Parent, and such charters, by-laws or comparable
organizational documents are in full force and effect.
Section 5.2 CAPITALIZATION. The authorized capital stock of the Company
consists of (a) 10,000,000 shares of Company Common Stock, par value $0.01 per
share, and (b) 5,000,000 shares of preferred stock, par value $0.01 per share
(the "COMPANY PREFERRED STOCK"). As of the date hereof, (i) 3,009,395 shares of
Company Common Stock were outstanding and no shares of Company Common Stock were
held by the Company or any Company Subsidiary, (ii) 405,200 shares of Company
Common Stock were reserved for issuance pursuant to Outstanding Options, and
(iii) no shares of Company Preferred Stock were outstanding. All of the shares
of outstanding Company Common Stock were validly issued, fully paid and
non-assessable. SECTION 5.2 of the Company Disclosure Schedule contains a
correct and complete list as of the date hereof of each outstanding option to
purchase Shares under the Stock Option Plan and Puls Agreement, including the
holder, date of grant, exercise price, expiration date and number of Shares
subject thereto. Each of the outstanding shares of capital stock or other
securities of each Company Subsidiary is duly authorized, validly issued, fully
paid and nonassessable and owned by the Company or another Company Subsidiary,
free and clear of any lien, pledge, security interest, right of first refusal,
agreement limitation on voting rights, claim or other encumbrance. As of the
date hereof, there are no bonds, debentures, notes or other evidences of
indebtedness having the right to vote on any matters on which the Company's
shareholders may vote ("COMPANY VOTING DEBT") issued or outstanding. Except as
set forth in SECTION 5.2 of the Company Disclosure Schedule, there are no
options, warrants, calls or other rights, agreements or commitments outstanding
obligating the Company to issue, reserve for issuance, deliver or sell shares of
its capital stock or debt securities, or obligating the Company to grant, extend
or enter into any such option, warrant, call or other such right, agreement or
commitment.
Section 5.3 AUTHORITY RELATIVE TO THIS AGREEMENT. The Board of
Directors of the Company has duly approved the Merger and this Agreement in
accordance with Section 1101 of the CGCL and has resolved to recommend the
approval of this Agreement by the Company's shareholders and directed that this
Agreement be submitted to the Company's shareholders for approval; provided such
recommendation may be modified or withdrawn as contemplated by SECTION 8.8 or if
the Board of Directors of the Company determines in good faith, and after
consultation with independent counsel, that such action is necessary to properly
discharge its fiduciary duties. The Company has the requisite corporate power
and authority to enter into this Agreement and, subject to approval of this
Agreement by the affirmative vote of the holders of a majority of the
outstanding shares of Company Common Stock, in accordance with the provisions of
the CGCL and the Company's Articles of Incorporation and By-Laws, as amended, to
carry out its obligations hereunder and consummate the transactions contemplated
hereby. The execution, delivery and performance of this Agreement by the Company
and the consummation of the transactions contemplated hereby by the Company have
been duly authorized by all necessary corporate action on the part of the
Company (except for the approval by affirmative vote of the holders of a
majority of the outstanding shares of Company Common Stock in accordance with
the provisions of the CGCL and the Company's Articles of Incorporation and
By-Laws). This Agreement has been duly executed by the Company and constitutes a
<PAGE>
12
valid and binding obligation of the Company enforceable in accordance with its
terms except as enforcement may be limited by bankruptcy, insolvency or other
similar laws affecting the enforcement of creditors' rights generally. Except as
set forth in SECTION 5.3 of the Company Disclosure Schedule, neither the
execution and delivery of this Agreement nor the consummation of the
transactions contemplated hereby will (a) conflict with or violate the charter,
bylaws or the equivalent organizational documents of the Company or any of its
Subsidiaries, or (b) result in any breach or constitute a default (with or
without notice or lapse of time, or both) under, or give rise in others to any
rights of termination, cancellation or acceleration under, any agreement,
indenture, contract, loan agreement, license, franchise, permit, order, decree,
concession, lease, instrument, judgment, statute, law, ordinance, rule or
regulation applicable to the Company or any Company Subsidiary or its or their
respective assets, other than, in the case of clause (b) only, such breaches,
defaults, violations and losses of rights that would not have a Company Material
Adverse Effect and the laws and regulations referred to in the next sentence.
Except as disclosed in SECTION 5.3 of the Company Disclosure Schedule or in
connection or in compliance with the provisions of the HSR Act (which filing has
been made), the Exchange Act, and the corporation, securities or blue sky laws
or regulations of the various states, no filing or registration with, or
authorization, consent or approval of, any governmental or regulatory body or
authority is necessary for the consummation by the Company of the Merger or the
other transactions contemplated hereby, except where the failure to make such
filing or registration or obtain such authorization, consent or approval would
not have a Company Material Adverse Effect or prevent or materially delay
consummation of the Merger.
Section 5.4 REPORTS AND FINANCIAL STATEMENTS.
(a) Since April 30, 1995, the Company has filed all reports
and other documents that it was required to file with the Securities
and Exchange Commission (the "COMMISSION"). The Company has furnished
Parent with true and complete copies of its (i) Annual Reports on Form
10-K for the fiscal years ended April 30, 1996 and April 30, 1997, as
filed with the Commission, (ii) Quarterly Reports on Form 10-Q for the
quarters ended July 31, 1997, October 31, 1997, and January 31, 1998 as
filed with the Commission, (iii) proxy statements related to all
meetings of its shareholders (whether annual or special) held since
April 30, 1996, and (iv) all reports on Forms 8-K filed with, and
registration statements declared effective by, the Commission since
April 30, 1996, except registration statements on Form S-8 relating to
employee benefit plans, which are all the documents (other than
preliminary material and Reports on Form 10-Q not referred to in clause
(ii) above) that the Company was required to file with the Commission
from April 30, 1996 to the date hereof (clauses (i) through (iv) being
referred to herein collectively as the "COMPANY SEC REPORTS"). As of
their respective dates, the Company SEC Reports complied in all
material respects with the applicable requirements of the Securities
Act of 1933, as amended (the "SECURITIES ACT"), or the Exchange Act, as
the case may be, and the rules and regulations of the Commission
thereunder applicable to such Company SEC Reports. As of their
respective dates, the Company SEC Reports did not contain any untrue
statement of a material fact or omit to state a material fact required
<PAGE>
13
to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they were made, not misleading.
(b) The financial statements included or incorporated by
reference in the Company SEC Reports (i) have been prepared in
accordance with generally accepted accounting principles applied on a
consistent basis ("GAAP") during the periods presented (except as may
be indicated therein or in the notes thereto or, in the case of the
unaudited statements, to normal year-end audit adjustments), (ii)
present fairly, in all material respects, the consolidated financial
position of the Company and the Company Subsidiaries as at the dates
thereof and the consolidated results of their operations and cash flow
for the periods then ended subject, in the case of the unaudited
interim financial statements, to normal year-end audit adjustments and
any other adjustments described therein and the fact that certain
information and notes have been condensed or omitted in accordance with
the Exchange Act and the rules promulgated thereunder, and (iii) are in
all material respects, in accordance with the books of account and
records of the Company.
(c) Neither the Company nor any Company Subsidiary has any
liability or is subject to any loss contingency, other than (i) as
reflected or disclosed in the financial statements or notes thereto
included in the Company SEC Reports, (ii) in the aggregate adequately
provided for in the Company's unaudited balance sheet (including any
related notes thereto) as of January 31, 1998 (the "1998 COMPANY
BALANCE SHEET"), (iii) incurred in the ordinary course of business and
not required under GAAP to be reflected on the 1998 Company Balance
Sheet, (iv) incurred since January 31, 1998 in the ordinary course of
business consistent with past practice, (v) incurred in connection with
this Agreement, (vi) as set forth in SECTIONS 5.4, 5.5, 5.6, 5.7, 5.8,
5.10 and 5.14 of the Company Disclosure Schedule, or (vii) which would
not have a Company Material Adverse Effect.
Section 5.5 ABSENCE OF CERTAIN CHANGES OR EVENTS; LITIGATION. Except as
disclosed in the Company SEC Reports or as disclosed in SECTION 5.5 of the
Company Disclosure Schedule, since April 30, 1997:
(a) there has not been (i) any events which, individually or
in the aggregate, have had or are reasonably likely to have a Company
Material Adverse Effect; (ii) any declaration, setting aside or payment
of any dividend or other distribution in respect of the capital stock
of the Company; or (iii) any material change by the Company in
accounting principles, practices or methods;
(b) there has not been any increase in the compensation
payable or that could become payable by the Company or any Company
Subsidiary to executive officers or any amendment of any of the plans
described in SECTION 5.6 (other than increases or amendments in the
ordinary course);
(c) there are no civil, criminal or administrative actions,
suits, claims, hearings, investigations or proceedings (i) pending or,
to the knowledge of the executive officers of the Company, threatened
against the Company or any Company Subsidiary or (ii) to the knowledge
<PAGE>
14
of the executive officers of the Company, pending against any current
or former director or executive officer of the Company in their
capacity as such, in the case of each of (i) and (ii) that,
individually or in the aggregate, would have a Company Material Adverse
Effect;
(d) there are no outstanding orders, judgments, injunctions,
awards or decrees of any Governmental Entity (as defined in SECTION
9.1) against the Company or any Company Subsidiary, any of its or their
properties, assets or business, or, to the knowledge of the executive
officers of the Company, any of its or their current or former
directors or executive officers in their capacity as such, except as
would not have, individually or in the aggregate, a Company Material
Adverse Effect; and
(e) the Company and the Company Subsidiaries have conducted
their business in the ordinary course in all material respects.
Section 5.6 BENEFIT PLANS; EMPLOYEES AND EMPLOYMENT PRACTICES.
(a) SECTION 5.6(A) of the Company Disclosure Schedule sets
forth a true and complete list of each of the following to which the
Company or any Company Subsidiary is a party or by which it is bound or
pursuant to which it may be required to make any payment:
(i) other than those described in SECTION 5.6(B) of
the Company Disclosure Schedule, each retirement, savings,
thrift, deferred compensation, severance, stock ownership,
stock purchase, stock option, performance, bonus, incentive,
vacation or holiday pay, hospitalization or other medical,
disability, life or other insurance, or other welfare, retiree
welfare or benefit plan, policy, trust, understanding or
arrangement of any kind, whether written or oral (THE
"NON-ERISA PLANS"); and
(ii) other than the Non-ERISA Plans and other than
those described in Section 5.6(b) of the Company Disclosure
Schedule, each employee collective bargaining agreement and
each agreement, commitment, understanding, plan, policy or
arrangement of any kind, whether written or oral, with or for
the benefit of any current or former officer, director,
employee or consultant (including, without limitation, each
employment, compensation, deferred compensation, severance,
supplemental pension, life insurance, termination or
consulting agreement or arrangement and any agreements or
arrangements associated with a change in control) (the
"COMPENSATION COMMITMENTS").
True and complete copies of all written Non-ERISA Plans and
Compensation Commitments and of all related insurance and annuity
policies and contracts and other documents with respect to each
Non-ERISA Plan and Compensation Commitment have been delivered to
Parent. SECTION 5.6(A) of the Company Disclosure Schedule contains a
true and complete description of all oral Non-ERISA Plans and
Compensation Commitments. Except as set forth in SECTION 5.6(A) of the
<PAGE>
15
Company Disclosure Schedule, no payments under any Non-ERISA Plan or
Compensation Commitment will be triggered as a result of the Merger.
(b) (i) SECTION 5.6(B) of the Company Disclosure Schedule sets
forth a true and complete list of each "employee pension
benefit plan" (as such term is defined in Section 3(2) of the
Employee Retirement Income Security Act of 1974, as amended
("ERISA")) covering any employee or former employee of the
Company or any Company Subsidiary (the "PENSION PLANS") and
each "employee welfare benefit plan" (as such term is defined
in Section 3(1) of ERISA) covering any employee or former
employee of the Company or any Company Subsidiary (the
"WELFARE PLANS") (collectively the "PLANS"). Except as
disclosed in SECTION 5.6(B) of the Company Disclosure
Schedule: (A) neither the Company nor any Company Subsidiary
has ever maintained any defined benefit Pension Plan, and (B)
none of the Company or any Company Subsidiary, or any other
person or entity that, together with the Company and the
Company Subsidiaries, is treated as a single employer under
Section 414 of the Code (an "ERISA AFFILIATE") has ever been
required to contribute to any "multiemployer plan" (as such
term is defined in Section 3(37) of ERISA).
(ii) The Company has delivered to Parent, with
respect to each Plan, correct and complete copies, where
applicable, of (A) all Plan documents and amendments, trust
agreements and insurance and annuity contracts and policies,
(B) the most recent determination letter received from the
Internal Revenue Service, (C) the Annual Reports (Form 5500
Series) and accompanying schedules, as filed, for the most
recently completed three Plan years, and (D) the current and
most recent summary plan description.
(iii) Each Plan which is intended to qualify under
Section 401(a) of the Code has received a favorable
determination letter from the Internal Revenue Service that
such Plan is so qualified under the Code or a request for a
determination letter has been submitted to the Internal
Revenue Service; and, to the knowledge of the executive
officers of the Company, no circumstance exists which would
cause a Plan which is so qualified to cease being so
qualified.
(c) Except as disclosed in SECTION 5.6(C) of the Company
Disclosure Schedule: (i) each Plan complies, and has been administered
to comply, with all requirements of law and regulations applicable
thereto, except as would not result in a Company Material Adverse
Effect, and the Company has received no notice from any governmental
authority questioning or challenging such compliance and there are no
actions, suits or claims (other than routine claims for benefits)
pending or, to the knowledge of the executive officers of the Company,
threatened involving such Plans or the assets of such Plans, except as
would not result in a Company Material Adverse Effect; (ii) neither the
Company nor any Company Subsidiary has any obligations under any of the
Welfare Plans or otherwise to provide health or death benefits to or in
respect of former employees, except as specifically required by the
continuation requirements of Part 6 of Title I of ERISA; and (iii)
neither the Company nor any Company Subsidiary has any liability of any
kind whatsoever, whether direct, indirect, contingent or otherwise, on
account of (A) any violation of the health care requirements of Part 6
<PAGE>
16
of Title I of ERISA or Section 4980B of the Code, (B) under Section
502(i) or Section 502(l) of ERISA or Section 4975 of the Code, (C)
under Section 302 of ERISA or Section 412 of the Code or (D) under
Title IV of ERISA, except as would not result in a Company Material
Adverse Effect.
(d) As of the date of this Agreement, except as disclosed in
SECTION 5.6(D) of the Company Disclosure Schedule, there are no
controversies, strikes, work stoppages or disputes pending between the
Company or any Company Subsidiary and any current or former employees
except such as would not result in a Company Material Adverse Effect.
To the knowledge of the executive officers of the Company, no
organizational effort by any labor union or other collective bargaining
unit currently is under way with respect to any employees of the
Company and the Company Subsidiaries. Neither the Company nor any
Company Subsidiary is a party to any labor union contract or collective
bargaining agreements with respect to persons employed by the Company
and the Company Subsidiaries. Neither the Company nor any Company
Subsidiary has engaged in any unfair labor practice, and there is no
unfair labor practice complaint pending against the Company or any
Company Subsidiary, in either case that would result in a Company
Material Adverse Effect.
Section 5.7 TAXES. (a) The following definitions apply to the terms set
forth below when used in this Agreement:
(i) "TAX" (and, with correlative meaning, "TAXES")
shall mean: (i) any federal, state, local or foreign net
income, gross income, gross receipts, windfall profit,
severance, property, production, sales, use, license, excise,
franchise, employment, payroll, withholding, alternative or
add-on minimum, ad valorem, value-added, transfer, stamp, or
environmental tax, or any other tax, custom, duty,
governmental fee or other like assessment or charge of any
kind whatsoever, together with any interest or penalty,
addition to tax or additional amount imposed by any
governmental authority; and (ii) any liability of the Company
or any Company Subsidiary for the payment of amounts with
respect to payments of a type described in clause (i) as a
result of being a member or an affiliated, consolidated,
combined or unitary group, or as a result of any obligation of
the Company or any Company Subsidiary under any Tax Sharing
Arrangement or Tax indemnity arrangement.
(ii) "TAX RETURN" shall mean any return, report or
similar statement required to be filed with any governmental
agency or other governmental authority with respect to any Tax
(including any attached schedules), including, without
limitation, any information return, claim for refund, amended
return or declaration of estimated Tax.
<PAGE>
17
(iii) "TAX SHARING ARRANGEMENT" shall mean any written
or unwritten arrangement for the allocation or payment of Tax
liabilities or payment for Tax benefits with respect to a
consolidated, combined or unitary Tax Return which Tax Return
includes or has included the Company or any Company
Subsidiary.
(b) Except as set forth in SECTION 5.7 of the Company
Disclosure Schedule, (i) the Company and each Company Subsidiary have
filed all Tax Returns required to be filed and have paid all Taxes
shown to be due on such Tax Returns, except those where the failure to
file or pay would not, individually or in the aggregate, result in a
Company Material Adverse Effect; (ii) all Tax Returns filed by the
Company and each Company Subsidiary are complete and accurate in all
material respects; (iii) to the knowledge of the executive officers of
the Company, neither the Company nor any Company Subsidiary has waived
in writing any statute of limitations in respect of Taxes that is
currently in effect; (iv) to the knowledge of the executive officers of
the Company, there is no action, suit, investigation, audit, claim or
assessment pending or proposed or threatened in writing with respect to
Taxes of the Company or any Company Subsidiary; (v) all material
deficiencies successfully asserted or material assessments successfully
made as a result of any examination of the Tax Returns referred to in
clause (i) and that have become due and payable have been paid in full;
(vi) there are no material liens for Taxes upon the assets of the
Company or any Company Subsidiary; (vii) all Taxes which the Company or
any Company Subsidiary are required by law to withhold or to collect
for payment have been duly withheld and collected, and have been paid
or accrued, reserved against and entered on the books of the Company,
except where the failure to withhold or collect for payment would not
result in a Company Material Adverse Effect; and (viii) to the
knowledge of the executive officers of the Company, neither the Company
nor any Company Subsidiary has been a member of any group of
corporations filing Tax Returns on a consolidated, combined, unitary or
similar basis other than each such group of which it is currently a
member.
(c) No transaction contemplated by this Agreement is subject
to withholding under Section 1445 of the Code (relating to "FIRPTA")
and no stock transfer Taxes, sales Taxes, use Taxes, real estate
transfer Taxes, or other similar Taxes will be imposed on the
transactions contemplated by this Agreement, other than Taxes for which
neither the Company, Parent or Sub are liable.
(d) Since the 1998 Company Balance Sheet date, the Company has
not prepared or filed any Tax Return inconsistent with past practice
or, on any such Tax Return, taken any position, made any election, or
adopted any method that is inconsistent with positions taken, elections
made or methods used in preparing or filing similar Tax Returns in
prior periods.
(e) As a result of the transactions contemplated by this
Agreement (including the termination of employment of any employee of
the Company or any Company Subsidiary after the Effective Date),
neither the Company nor any Company Subsidiary will be obligated to
<PAGE>
18
make a payment (i) that would be a "parachute payment" to an individual
that is currently a "disqualified individual" with respect to the
Company as those terms are defined in Section 280G of the Code, without
regard to whether such payment is reasonable compensation for personal
services performed or to be performed in the future or (ii) of
compensation that would not be deductible under Section 162 of the
Code.
Section 5.8 ENVIRONMENTAL MATTERS. Except as set forth in SECTION 5.8
of the Company Disclosure Schedule, and to the knowledge of the executive
officers of the Company: (i) the operations of the Company comply and have
complied with all Environmental Laws applicable to it including, without
limitation, with respect to the handling and disposal of Hazardous Material,
except as would not have a Company Material Adverse Effect; (ii) the Company
maintains all permits required pursuant to Environmental Laws applicable to it,
except as would not have a Company Material Adverse Effect and is not party to
any judicial or administrative proceeding alleging the violation of any
Environmental Law applicable to it; (iii) none of the Company's operations or
properties is the subject of an investigation by a governmental authority
evaluating whether any remedial action is needed to respond to a release of
Hazardous Material into the environment; (iv) the Company has not filed any
notice under any Environmental Law applicable to it reporting a spill or release
of a Hazardous Material into the environment; and (v) the Company (or its
predecessors in interest) has not arranged for, or transported, disposed,
released or spilled any Hazardous Material at the Company's facilities or at any
other location, except as would not result in a Company Material Adverse Effect.
For the purposes of this SECTION 5.8, "ENVIRONMENTAL LAWS" shall mean any
federal, state, or local law, rule, regulation or other binding order or
determination of any governmental authority, including permits, relating to or
imposing liability or standards of care with respect to pollution, protection of
the environment or occupational safety and health; and "HAZARDOUS MATERIAL"
shall mean any pollutant, contaminant, hazardous substance, toxic substance,
hazardous waste or any constituent of such substances or wastes regulated under
Environmental Laws including, without limitation, petroleum, including any
fraction thereof, radioactive material, asbestos and polychlorinated biphenyls.
Section 5.9 INTELLECTUAL PROPERTY MATTERS. SECTION 5.9 of the Company
Disclosure Schedule contains a list of all trademarks, copyrights, and patents
owned by the Company. Except as set forth in SECTION 5.9 of the Company
Disclosure Schedule, the Company or a Company Subsidiary owns, or is licensed or
otherwise possess legally enforceable rights to use, all trademarks, copyrights,
patents and other intellectual property that are used in the business of the
Company and the Company Subsidiaries as currently conducted, except as would
not, individually or in the aggregate, have a Company Material Adverse Effect.
Section 5.10 MATERIAL CONTRACTS. Except for such failures as set forth
in SECTION 5.10 of the Company Disclosure Schedule or as would not have a
Company Material Adverse Effect, the Company and the Company Subsidiaries have
substantially performed their respective obligations under each lease, contract
or other agreement to which it is a party and under which the consequences of a
default or termination would have a Company Material Adverse Effect (the
"MATERIAL CONTRACTS").
<PAGE>
19
Section 5.11 COMPLIANCE WITH LAWS; PERMITS. Except as set forth in the
Company SEC Reports or SECTION 5.11 of the Company Disclosure Schedule, the
businesses of each of the Company and the Company Subsidiaries are being
conducted in compliance with applicable federal, state, local and foreign laws
(collectively, "LAWS"), except for such violations that, individually or in the
aggregate, would not have a Company Material Adverse Effect. Except as set forth
in SECTION 5.11 of the Company Disclosure Schedule, the Company and the Company
Subsidiaries each has all permits, license, franchises, variances, exemptions,
orders and other governmental authorizations, consents and approvals (the
"COMPANY LICENSES") necessary to own or lease and operate their respective
properties and conduct its business as presently conducted except those the
absence of which, individually or in the aggregate, would not have a Company
Material Adverse Effect.
Section 5.12 TAKEOVER STATUTES. No "fair price," "moratorium," "control
share acquisition" or other similar anti-takeover statute or regulation (each a
"TAKEOVER STATUTE") or any applicable anti-takeover provision in the Company's
Articles of Incorporation and By-Laws or any shareholder rights agreement is, or
at the Effective Date will be, applicable to the Company, the Shares, the Merger
or the other transactions contemplated by this Agreement or the Company Holder
Agreement. Assuming the accuracy of Parent's representations and warranties
contained in SECTION 4.5, the Board of Directors of the Company has taken all
action so that Parent will not become an "Interested Party" pursuant to Section
1203 of the CGCL.
Section 5.13 FAIRNESS OPINION. The Company has received the written
opinion of SBC Warburg Dillon Read, Inc., financial advisors to the Company (the
"COMPANY FINANCIAL ADVISOR"), as of the date of delivery of such opinion, to the
effect that the Per Share Merger Consideration paid to the Holders pursuant to
SECTION 3.2 is fair to the shareholders of the Company from a financial point of
view.
Section 5.14 FINANCIAL ADVISOR. Except as set forth in SECTION 5.14 of
the Company Disclosure Schedule, no broker, finder or investment banker is
entitled to any brokerage, finder's or other fee or commission in connection
with the Merger or the transactions contemplated by this Agreement based upon
arrangements made by or on behalf of the Company. A complete and correct copy of
all agreements referenced in SECTION 5.14 of the Company Disclosure Schedule
have been provided to Parent.
Section 5.15 INDUSTRY CONDITIONS. Except as set forth in SECTION 5.15
of the Company Disclosure Schedule, as of the date of this Agreement, the
executive officers of the Company have no knowledge of any pending or proposed
consolidation effecting any current customer or supplier of the Company or the
non-availability of any parts or components required by the Company or the
Company Subsidiaries that would be materially adverse to the business,
operations or financial condition of the Company and the Company Subsidiaries
taken as a whole.
Section 5.16. CUSTOMERS. Except as set forth in SECTION 5.16 of the
Company Disclosure Schedule, as of the date of this Agreement no single customer
<PAGE>
20
or group of related customers accounts for more than ten percent of the
consolidated revenues of the Company and the Company Subsidiaries for the most
recent 12 full calendar months.
Section 5.17. COMPANY MATERIAL ADVERSE EFFECT. For purposes of this
Agreement, "COMPANY MATERIAL ADVERSE EFFECT" means any change, effect,
circumstance or event that is materially adverse to the business, operations or
financial condition of the Company and the Company Subsidiaries taken as a
whole, other than changes, effects, circumstances or events: (i) set forth in
SECTION 5.5 of the Company Disclosure Schedule, (ii) affecting the Company's and
the Company Subsidiaries' industry generally or resulting from general industry
trends, including, without limitation, the consolidation of hospitals and other
healthcare providers or affecting the Company's customers, the consolidation of
suppliers of parts and components used in the business of the Company and the
Company's Subsidiaries, the non-availability of parts and components required by
the Company and the Company Subsidiaries, or actions by competitors of the
Company or the Company Subsidiaries, (iii) resulting from general economic
conditions or continuing trends with respect to Company operating losses or
liquidity concerns or (iv) resulting from the transactions contemplated by this
Agreement or the announcement thereof, it being agreed that any change, effect,
circumstance or event shall be presumed, unless there is clear evidence to the
contrary, to have resulted from the transactions contemplated by this Agreement
or the announcement thereof.
Section 5.18. KNOWLEDGE. Any reference herein to "the knowledge of the
executive officers of the Company" or words of similar importance shall mean to
the actual knowledge of the officers of the Company and the employees identified
in Section 5.18 of the Company Disclosure Schedule.
ARTICLE VI
REPRESENTATIONS AND WARRANTIES REGARDING SUB
Parent and Sub jointly and severally represent and warrant to the
Company as follows:
Section 6.1 ORGANIZATION. Sub is a corporation duly organized, validly
existing and in good standing under the laws of the State of California.
Complete and correct copies of the Articles of Incorporation and By-Laws of Sub
have been delivered to the Company.
Section 6.2 CAPITALIZATION. The authorized capital stock of Sub
consists of 1,000 shares of common stock, par value $0.01 per share, all of
which shares are validly issued and outstanding, fully paid and nonassessable
and are owned by a wholly owned subsidiary of Parent free and clear of all
liens, claims and encumbrances.
Section 6.3 AUTHORITY RELATIVE TO THIS AGREEMENT. Sub has the requisite
corporate power and authority to enter into this Agreement and to carry out its
obligations hereunder and consummate the transactions contemplated hereby. The
execution, delivery and performance of this Agreement by Sub and the
consummation of the transactions contemplated hereby by Sub have been duly
authorized by all necessary corporate action on the part of Sub, including any
necessary action of Sub's shareholder. This Agreement has been duly executed by
Sub and constitutes a valid and binding obligation of Sub enforceable in
accordance with its terms except as enforcement may be limited to bankruptcy,
<PAGE>
21
insolvency or other laws affecting the enforcement of creditors' rights
generally and except that the availability of equitable remedies, including
specific performance, is subject to the discretion of the court before which any
proceeding therefor may be brought. Sub is not subject to or obligated under any
charter or by-law provision which would be breached or violated by its executing
and carrying out this Agreement. Except as referred to herein or in connection,
or in compliance, with the provisions of the HSR Act amended (which filing has
been made), the Exchange Act and the corporation, securities or blue sky laws or
regulations of the various states, no filing or registration with, or
authorization, consent or approval of, any governmental or regulatory body or
authority is necessary for the consummation by Sub of the Merger or the
transactions contemplated by this Agreement, except where the failure to make
such filing or registration or obtain such authorization, consent or approval
would not prevent or materially delay consummation of the Merger or have a
Parent Material Adverse Effect.
Section 6.4 SUB ACTION. The Board of Directors of Sub (at a meeting
duly called and held or by unanimous written consent in lieu of meeting) has by
the requisite vote or consent of directors approved the Merger and Merger
Agreement in accordance with the applicable provisions of Section 1101 of the
CGCL.
Section 6.5 INTERIM OPERATIONS OF SUB. Sub was formed solely for the
purpose of engaging in the transactions contemplated hereby, has engaged in no
other business activities and has conducted its operations only as contemplated
hereby. Sub is not a party to any contract or agreement other than this
Agreement.
ARTICLE VII
CONDUCT OF BUSINESS PENDING THE MERGER
Section 7.1 CONDUCT OF BUSINESS BY THE COMPANY. Prior to the Effective
Date or earlier termination of this Agreement, except as expressly contemplated
by this Agreement or as set forth in SECTION 7.1 of the Company Disclosure
Schedule, unless Parent shall otherwise agree in writing, which agreement shall
not be unreasonably withheld or delayed (except in the case of SECTIONS 7.1(B),
7.1(C)(I), 7.1(C)(II), 7.1(C)(III), 7.1(C)(IV), 7.1(C)(V), 7.1(C)(VII), 7.1(D),
and 7.1(E), where such agreement is within the sole discretion of Parent):
(a) subject to the limitations expressly contemplated by this
Agreement, the Company shall, and shall cause the Company Subsidiaries
to, carry on their respective operations in the usual and ordinary
course consistent with past practice, and shall use its commercially
reasonable efforts, and shall cause each of the Company Subsidiaries to
use its commercially reasonable efforts, to preserve substantially
intact its present business organization, keep available the services
of its present executive officers and key employees and preserve its
present relationships and goodwill with customers, suppliers,
creditors, lessors, employees and others having business dealings with
it to the end that its goodwill and on-going businesses shall not be
materially impaired at the Effective Date;
<PAGE>
22
(b) the Company shall not, nor shall it propose to, except as
required or permitted by this Agreement, (i) sell or pledge or agree to
sell or pledge any capital stock owned by it in any of the Company
Subsidiaries, (ii) amend its Articles of Incorporation or By-Laws,
(iii) split, combine or reclassify its outstanding capital stock or
issue or authorize or propose the issuance of any other securities in
respect of, in lieu of or in substitution for shares of the capital
stock, or declare, set aside or pay any dividend or other distribution
payable in cash, stock or property, or (iv) directly or indirectly
redeem, purchase or otherwise acquire or agree to redeem, purchase or
otherwise acquire any shares of its capital stock (except in connection
with any exercise of any existing stock option pursuant to which the
exercise price is paid in shares of the Company Common Stock);
(c) the Company shall not, nor shall it permit any of the
Company Subsidiaries to, (i) except as required by this Agreement,
issue, deliver or sell or agree to issue, deliver or sell any
additional shares of, or stock appreciation rights or rights of any
kind to acquire any shares of, its capital stock of any class, any
Company Voting Debt, or any option, rights or warrants to acquire, or
securities convertible into, shares of capital stock (except in
connection with the exercise of any existing stock option), (ii) amend
in any respect existing agreements evidencing any existing stock option
(including, without limitation, the exercise or strike prices thereof)
or the Stock Option Plan or the Puls Agreement pursuant to which such
options were granted, except as provided in SECTION 3.6 hereof, and
provided that the Company shall have the right to cancel any
Outstanding Options which will expire on their terms prior to July 30,
1998 in exchange for payment to the holders of such Outstanding Options
of an amount which shall not exceed the amount that would be payable to
such holder pursuant to SECTION 3.6 hereof, (iii) acquire, lease or
dispose or agree to acquire, lease or dispose of any capital assets, or
make any other capital expenditures, with a value, in the aggregate for
all such capital assets or other capital expenditures, in excess of
$50,000 (including in such calculation the proceeds of any
sale/leaseback transactions), (iv) (A) create, incur, assume or permit
additional indebtedness for borrowed money (including obligations in
respect of capital leases), other than loans and advances to and from
Company Subsidiaries and periodic drawdowns under the Company's credit
facilities existing as of the date hereof, provided that the amount
available under such facilities as of the date hereof is not increased,
(B) other than in the ordinary course of business consistent with past
practice, assume, guarantee, endorse or otherwise become liable or
responsible for the obligations of any other person, (C) other than in
the ordinary course of business consistent with past practice, encumber
or grant a security interest in any asset, or (D) other than in the
ordinary course of business consistent with past practice, make any
loans or advances to any other person, or enter into any agreement or
instrument relating to the borrowing of money or the extension of
credit, (v) acquire or agree to acquire by merging or consolidating
with, or by purchasing an equity interest in, or by any other manner,
any business or any corporation, partnership, association or other
business organization or division thereof, (vi) enter into any
contracts, agreements or other arrangements with vendors (A) pursuant
to which the Company or any of the Company Subsidiaries would be
obligated to purchase products or services from such vendors having a
<PAGE>
23
value in excess of $100,000 in any year or (B) which are not terminable
within six months without penalty (excluding contracts, agreements or
other arrangements entered into or assumed in the ordinary course of
business to satisfy customer requirements) or (vii) purchase, transfer,
lease, sell, mortgage, pledge, dispose of or encumber any real
property, (viii) effect any improvements or expansions thereof
(excluding maintenance and repairs in the ordinary course of business)
or (ix) in each case subject to the exclusions and exceptions set forth
above, adopt, enter into, amend or terminate any contract, agreement,
commitment or arrangement with respect to any of the foregoing;
(d) the Company shall not, nor shall it permit any of the
Company Subsidiaries to, except as required to comply with applicable
law, (i) adopt, enter into, terminate or amend any bonus, profit
sharing, compensation, severance, termination, stock option, pension,
retirement, deferred compensation, employment or other employee benefit
plan, agreement, trust, fund or other arrangement for the benefit or
welfare of any current or former director, officer or employee
(excluding arrangements not involving capital stock of the Company with
new employees in the ordinary course of business and consistent with
past practice), (ii) increase in any manner the compensation or fringe
benefits of any director, executive officer or employee (provided, that
the Company and the Company Subsidiaries shall be permitted to award
normal salary increases to employees (other than executive officers) of
the Company and the Company Subsidiaries in the ordinary course of
business that are consistent with past practice (including without
limitation in connection with any promotion of such employee) and that,
in the aggregate, do not result in a material increase in compensation
expense to the Company and the Company Subsidiaries relative to the
level in effect prior to such increase), (iii) pay any benefit not
provided under any existing plan or arrangement (excluding arrangements
not involving capital stock of the Company with new employees in the
ordinary course of business and consistent with past practice), (iv)
grant any awards under the Stock Option Plan or, except in the ordinary
course of business consistent with past practice and not involving the
capital stock of the Company, any other bonus, incentive, performance
or other compensation plan or arrangement (including, without
limitation, the grant of stock options, stock appreciation rights,
stock based or stock related awards, performance units or restricted
stock, or the removal of existing restrictions in any benefit plans or
agreements or awards made thereunder), (v) take any action to fund or
in any other way secure the payment of compensation or benefits under
any employee plan, agreement, contract or arrangement or employee
benefit plan, other than in the ordinary course of business consistent
with past practice, or (vi) adopt, enter into, amend or terminate any
contract, agreement, commitment or arrangement to do any of the
foregoing; provided, that notwithstanding the provisions of this clause
(d), the Company and the Company Subsidiaries shall be permitted to
settle disputes with employees, hire new employees and to promote
employees, provided that such settlements, hirings and promotions are
in the ordinary course of business consistent with past practice;
(e) the Company shall not, nor shall it permit the Company
Subsidiaries to, make any change in its accounting policies or
procedures, including without limitation its accounting for inventory
<PAGE>
24
and its practices in determining reserves, except as required under
generally accepted accounting principles;
(f) the Company shall not, nor shall it permit the Company
Subsidiaries to, modify, amend or terminate any Material Contract or
waive, release or assign any material rights or claims thereunder,
except in the ordinary course of business or as would not result in a
Company Material Adverse Effect;
(g) the Company shall not, nor shall it permit any Company
Subsidiary to, file any Tax Return or make any Tax election
inconsistent with past practice;
(h) the Company shall not, or shall it permit the Company
Subsidiaries, to settle or compromise any litigation, except for an
amount less than the amount set forth in SECTION 7.1(H) of the Company
Disclosure Schedule $50,000 in the aggregate; and
(i) the Company shall use reasonable efforts to refrain from
taking, and shall not permit any of the Company Subsidiaries to take,
any action that would, or reasonably might be expected to, result in
any of the conditions to the Merger set forth in ARTICLE IX not being
satisfied, or (unless such action is required by applicable law) that
would adversely affect the ability of the Company to obtain any of the
regulatory approvals required to consummate the Merger.
Section 7.2 REPORTS. All reports that the Company files with the
Commission after the date hereof and prior to the Effective Date or the earlier
termination of this Agreement shall, as of their respective dates, comply in all
material respects with the applicable requirements of the Exchange Act, and the
rules and regulations of the Commission thereunder applicable to such reports
and, as of their respective dates, shall not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading.
Section 7.3 OBLIGATIONS OF PARENT AND SUB; CONDUCT OF BUSINESS OF SUB.
Each of Parent and Sub shall use reasonable efforts to refrain from taking any
action that would, or reasonably might be expected to, result in any of the
conditions to the Merger set forth in ARTICLE IX not being satisfied, or (unless
such action is required by applicable law) that would adversely affect the
ability of Parent or Sub to obtain any of the regulatory approvals required to
consummate the Merger) and provided further that notwithstanding anything to the
contrary in this Agreement, neither Parent nor Sub shall be in any way obligated
to take any action in order to obtain the termination or expiration of the
waiting period under the HSR Act, except as provided in EXHIBIT D. During the
period from the date of this Agreement to the Effective Date, Sub shall not
engage in any activities of any nature except as provided in or contemplated by
this Agreement.
<PAGE>
25
ARTICLE VIII
ADDITIONAL AGREEMENTS
Section 8.1 ACCESS AND INFORMATION. Upon reasonable notice, the Company
and the Company Subsidiaries shall afford to Parent and to Parent's accountants,
counsel and other representatives full access during normal business hours (and
at such other times as the parties may mutually agree), and in a manner so as
not to interfere materially with the normal business operations of the Company
and the Company Subsidiaries, throughout the period prior to the Effective Date
to all of their properties, books, contracts, commitments, records and
personnel. During such period, the Company shall furnish promptly to Parent (i)
a copy of each report, schedule and other document filed or received by it
pursuant to the requirements of federal or state securities laws, and (ii) all
other information concerning the business, properties and personnel of the
Company and the Company Subsidiaries as Parent may reasonably request. Parent
and Sub shall hold, and shall cause its affiliates, employees and agents to
hold, in confidence all such information in accordance with the terms of the
Confidentiality Agreement, dated November 8, 1996, between Parent and Dillon,
Read & Co. (now known as SBC Warburg Dillon Read, Inc.) (on behalf of the
Company), as amended (the "CONFIDENTIALITY AGREEMENT"), and, in the event of
termination of this Agreement for any reason, will promptly comply with the
terms of the Confidentiality Agreement. During the period prior to the Effective
Date, upon Parent's reasonable request sufficiently in advance to allow the
Company to make arrangements therefore, the Company shall make its accountants,
counsel, lenders and other representatives available to Parent and to Parent's
accountants, counsel and other representatives at reasonable times.
Section 8.2 SHAREHOLDERS' MEETING. Subject to its fiduciary duties, as
determined by the Board of Directors of the Company after consultation with and
based upon the advice of independent legal counsel (who may be the Company's
regularly engaged independent legal counsel) or as contemplated by SECTION 8.8
in connection with the receipt by the Company of a Business Combination Proposal
(as defined in SECTION 8.8) that the Board of Directors of the Company
reasonably determines will result in a Superior Proposal (as defined in SECTION
8.8), as promptly as practicable:
(a) the Company shall take all action necessary, in accordance
with applicable law and its Articles of Incorporation, as amended, and
By-Laws, to call a special meeting of the holders of Company Common
Stock (the "COMPANY MEETING") for the purpose of considering and taking
action to authorize this Agreement and the Merger contemplated hereby
pursuant to the CGCL; and
(b) include in the Proxy Statement the recommendation of the
Board of Directors of the Company that holders of Company Common Stock
vote in favor of and approve the Merger and the adoption of this
Agreement at the Company Meeting.
At the Company Meeting, all of the shares of Company Common Stock then
owned by Parent, Sub or any other Parent Subsidiary, or with respect to which
<PAGE>
26
Parent, Sub or any other Parent Subsidiary holds the power to direct the voting,
will be voted in favor of approval of the Merger and adoption of this Agreement.
Section 8.3 PROXY STATEMENT.
(a) As promptly as reasonably practicable after the execution
of this Agreement, the Company shall prepare and file with the
Commission preliminary proxy materials with respect to the actions to
be taken at the Company Meeting, which, as to those matters relating to
Parent, shall be in form and substance reasonably satisfactory to
Parent. As promptly as reasonably practicable after comments are
received from the Commission with respect to such preliminary proxy
materials, the Company shall use reasonable efforts to respond to the
comments of the Commission. Parent shall provide the Company with such
information as may be required to be included in the proxy statement or
as may be reasonably required to respond to any comment of the
Commission. After all the comments received from the Commission have
been cleared by the Commission staff and all information required to be
contained in the proxy statement has been included therein by the
Company, the Company shall file with the Commission the Proxy Statement
and the Company shall use reasonable efforts to have the Proxy
Statement cleared by the Commission as soon thereafter as practicable.
The Company shall cause the Proxy Statement to be mailed to its
shareholders of record as promptly as reasonably practicable after
clearance by the Commission.
(b) Parent and the Company shall make all necessary filings
applicable to it with respect to the Merger under the Exchange Act and
the rules and regulations thereunder and under applicable blue sky or
similar securities laws and shall use its best reasonable efforts to
obtain required approvals and clearances with respect thereto.
Section 8.4 EMPLOYEE MATTERS.
(a) As of and after the Effective Date, Parent shall cause the
Surviving Corporation and the Company Subsidiaries to provide or
continue to provide such plans, programs, agreements or arrangements on
behalf of the employees of the Company and the Company Subsidiaries
immediately prior to the Effective Date ("AFFECTED EMPLOYEES") so as to
provide, in the aggregate, employee benefits which are substantially
equivalent or superior (including cost to the employees) to the
benefits provided to such Affected Employees immediately prior to the
Effective Date, and shall credit all past service of such Affected
Employees for all purposes under such plans, programs, agreements and
arrangements to the same extent such service was recognized immediately
prior to the Effective Date. To the extent that any Affected Employee
becomes eligible for participation in employee benefit plans and
programs maintained by Parent (the "PARENT BENEFIT PLANS"), such
Affected Employee's years of service with the Company and the Company
Subsidiaries prior to the Effective Date shall be recognized for
purposes of eligibility and vesting (including waiting periods and
pre-existing conditions), and, with respect to vacation and severance
plans, for purposes of benefit accrual and benefit determination.
<PAGE>
27
(b) Without limiting the foregoing, Parent shall cause the
Surviving Corporation and its subsidiaries to provide or continue to
provide severance benefits equal or superior to the severance benefits
described in SECTION 5.6(A) of the Company Disclosure Schedule, and
shall cause the Surviving Corporation and its subsidiaries to honor all
severance obligations to the Affected Employees in accordance with
their terms.
(c) As soon as practicable after the date hereof, but in no
event later than 10 days from the date hereof, the Company (after
consultation with and approval by Parent) shall take action (i) to
amend the Company's Employee Stock Purchase Plan to provide that a
participant in such plan may not increase his or her compensation
contribution percentages after the date of such amendment and (ii) to
provide that such Employee Stock Purchase Plan shall be terminated as
of the Effective Date.
(d) After the date of this Agreement and prior to the
Effective Date, the Company and the Company Subsidiaries, after
consultation with, and upon the consent of, Parent (which consent shall
not be unreasonably withheld), shall have the right to enter into
agreements with certain of its employees to pay retention bonuses after
consultation with Parent, and upon such terms and conditions as the
Company may reasonably determine are necessary to retain the services
of such employees through, and in some cases, beyond, the Effective
Date, provided that the amount of such bonuses shall not exceed
$250,000 in the aggregate.
(e) Prior to the Effective Date, (i) Parent shall contact
employees of the Company and the Company Subsidiaries respecting
employment or termination of employment after the Effective Date only
with the prior consent of the Company which consent shall not be
unreasonably withheld, and Parent shall consult with the Company as to
the terms and conditions thereof and (ii) Parent shall cooperate with,
and shall take such actions as the Company may reasonably request, with
respect to the transition of the employees of the Company and the
Company Subsidiaries, with a view to preserving the relationship and
goodwill of the Company and the Company Subsidiaries with their
employees.
(f) No provision of this SECTION 8.4 shall create any
third-party beneficiary rights in any employee or former employee
(including any beneficiary or dependent thereof) of Parent, the
Company, any Company Subsidiary, or any of their affiliates in respect
of continued employment (or resumed employment) for any specified
period of any nature or kind whatsoever.
(g) In the event this Agreement is terminated prior to the
Effective Date, without the prior written consent of the Company,
neither the Medical Systems division of Parent nor Sub shall for a
period of one year after the date on which this Agreement is
terminated, directly or indirectly solicit for employment, any person
or persons employed by the Company or any Company Subsidiary at any
time prior to the time this Agreement is terminated. The foregoing
restriction on solicitation of employment shall not be deemed to apply
to unsolicited inquiries concerning possible employment which are
<PAGE>
28
received by Parent, Sub or any Parent Subsidiary from or on behalf of
such person, nor shall it apply to general solicitations of employment
not specifically directed toward any such employees of the Company or
any Company Subsidiary.
Section 8.5 INDEMNIFICATION.
(a) From and after the Effective Date, to the fullest extent
permitted under the CGCL, Parent shall indemnify, defend and hold
harmless each current and former officer, director or employee of the
Company or any Company Subsidiary (together with their respective
successors, assigns, heirs, executors, administrators and
representatives, the "INDEMNIFIED PARTIES") against all investigations,
actions, suits, proceedings, judgments, costs, fines, amounts paid in
settlement, losses, expenses (including, without limitation, reasonable
attorneys' fees and ancillary related costs), claims, damages or
liabilities, whether civil, criminal, administrative or investigative,
arising in whole or in part out of, or based in whole or in part on,
any matter existing or occurring at or prior to the Effective Date or
out of the transactions contemplated by this Agreement. In the event of
any such claim, action, suit, proceeding or investigation (whether
arising before or after the Effective Date), (i) any counsel retained
by the Indemnified Parties for any period after the Effective Date
shall be reasonably satisfactory to Parent, (ii) after the Effective
Date, Parent shall pay the reasonable fees and expenses of such
counsel, promptly after statements therefor are received, and (iii)
Parent shall, and shall cause the Surviving Corporation to, cooperate
in the defense of any such matter; provided, however, that Parent shall
not be liable for any settlement effected without its written consent
(which consent shall not be unreasonably withheld or delayed). The
Indemnified Parties as a group may retain only one law firm to
represent them with respect to any single action unless there is, under
applicable standards of professional conduct, a conflict between the
positions of any two or more Indemnified Parties. The indemnity
agreements of Parent in this SECTION 8.5(A) shall extend, on the same
terms to, and shall inure to the benefit of and shall be enforceable
by, each person or entity who controls, or in the past controlled, any
present or former director, officer or employee of the Company or any
of the Company Subsidiaries.
(b) Parent agrees that all rights to indemnification existing
in favor of the current or former directors, officers or employees of
the Company or any Company Subsidiary under the Company's Articles of
Incorporation, as amended, and By-Laws as in existence on the date
hereof arising in whole or in part out of, or based in whole or in part
on, any matter existing or occurring at or prior to the Effective Date,
shall survive the Merger and shall continue in full force and effect in
respect of claims made during a period of ten years from the Effective
Date, and Parent shall guaranty the obligations of the Surviving
Corporation in respect thereof.
(c) The Surviving Corporation shall honor and fulfill in all
respects the obligations of the Company pursuant to the indemnification
agreements with the Company's directors and executive officers existing
at the date hereof and Parent shall guaranty the obligations of the
<PAGE>
29
Surviving Corporation in respect thereto. True and correct copies of
such indemnification agreements have been furnished to Parent.
(d) This SECTION 8.5 is intended for the benefit of, and shall
be enforceable by, the persons referenced herein and their respective
heirs and/or personal representatives, and shall be binding upon Parent
and its successors and assigns.
Section 8.6 ANTITRUST MATTERS. The Company and Parent have filed
notifications under the HSR Act in connection with the Merger and the
transactions contemplated hereby. The Company, Parent and Sub shall use their
reasonable efforts to respond as promptly as practicable to all inquiries and
requests received from any State Attorney General or other governmental
authority in connection with antitrust matters relating to the transactions
contemplated by this Agreement.
Section 8.7 REASONABLE EFFORTS; NOTIFICATION.
(a) Subject to the terms and conditions of this Agreement,
including SECTION 8.8, each of the parties hereto agrees to cooperate
with each other and use reasonable efforts to take, or cause to be
taken, all actions and to do, or cause to be done, in each case
consistent with the fiduciary duties of their respective Boards of
Directors, all things necessary, proper or advisable (i) under
applicable laws and regulations to consummate and make effective the
transactions contemplated by this Agreement as soon as reasonably
practicable, including to obtain all necessary waivers, consents and
approvals, to effect all necessary registrations and filings
(including, but not limited to, filings with all applicable
Governmental Entities) and (ii) to lift any injunction or other legal
bar to the Merger as soon as reasonably practicable (and, in such case,
to proceed with the Merger as expeditiously as possible); provided,
however, that notwithstanding anything to the contrary in this
Agreement, neither Parent nor Sub shall be in any way obligated to take
any action in order to obtain the termination of the waiting period
under the HSR Act, except as provided in EXHIBIT D.
(b) Parent shall give prompt notice to the Company, and the
Company shall give prompt notice to Parent, of: (i) the occurrence or
non-occurrence of any event of which it has knowledge, the occurrence
or non-occurrence of which would cause (A) any representations or
warranties contained in this Agreement to be untrue or inaccurate in
any material respect, (B) any of its covenants, conditions or
agreements contained in this Agreement not to be complied with or
satisfied or (C) a need to supplement the Proxy Statement; and (ii) any
failure of Parent or the Company, as the case may be, to comply with or
satisfy any of its covenants, conditions or agreements to be complied
with or satisfied by it hereunder; provided, that the delivery of any
notice pursuant to this SECTION 8.7 shall not limit or otherwise affect
the remedies available hereunder to the party receiving such notice.
<PAGE>
30
Section 8.8 NO SOLICITATION.
(a) Prior to the Effective Date or the earlier termination of
this Agreement pursuant to SECTION 10.1, the Company shall not,
directly or indirectly, take (nor shall the Company authorize or permit
any Company Subsidiary or its or their officers, directors, employees,
representatives, investment bankers, financial advisors, attorneys,
accountants or other agents or affiliates, to take) any action to (i)
encourage, solicit or initiate the submission of any Business
Combination Proposal (as defined below), (ii) enter into any agreement
with respect to any Business Combination Proposal or (iii) participate
in any way in discussions or negotiations with, or furnish any
non-public written information to, any person in connection with, or
take any other action to encourage the making of any proposal that
constitutes, or may reasonably be expected to lead to, any Business
Combination Proposal; provided, that the Company may (i) participate in
discussions or negotiations with or furnish information to any persons
or group (other than Parent or an affiliate of Parent) (a "THIRD
PARTY") that makes an unsolicited Business Combination Proposal that
the Board of Directors of the Company determines (after consultation
with its financial advisors) may reasonably be expected to result in a
Superior Proposal (as defined below), and enter into any
confidentiality agreement or standstill agreement with such Third Party
in connection with such a Business Combination Proposal (provided, that
any such information so furnished or any such confidentiality or
standstill agreements so entered into shall, at the time such
information is furnished or such agreement is entered into, be promptly
delivered to Parent), (ii) comply with Rule 14e-2 promulgated under the
Exchange Act with regard to any Business Combination Proposal (assuming
that such Business Combination Proposal includes a tender offer
requiring the Company's response pursuant to such Rule), (iii) fail to
make or withdraw or modify its recommendation referred to in SECTION
8.2 if there exists a Business Combination Proposal that is a Superior
Proposal or if the Board of Directors of the Company determines, in
good faith and after consultation with independent counsel, that such
action is required to discharge properly its fiduciary duties, or (iv)
after terminating this Agreement in accordance with Section 10.1(e)
enter into an agreement with respect to or recommend to its
shareholders a Business Combination Proposal that is a Superior
Proposal. Any actions permitted under, and taken in compliance with
this SECTION 8.8, shall not be deemed a breach of any other covenant or
agreement of the Company contained in this Agreement.
(b) Notwithstanding the foregoing, the Company may not enter
into an agreement with respect to or recommend to its shareholders a
Business Combination Proposal that is a Superior Proposal or fail to
make or withdraw or modify its recommendation referred to in SECTION
8.2 if there exists a Business Combination Proposal that is a Superior
Proposal unless (i) two business days shall have elapsed after delivery
to Parent of a written notice informing Parent of the terms and
conditions of the Business Combination Proposal, and (ii) Parent does
not, within such two business day period, make an offer which the Board
of Directors of the Company determines in good faith (based on the
advice of its financial adviser) to be as favorable to the Company's
shareholders as such Business Combination Proposal.
<PAGE>
31
(c) For purposes of this Agreement, "BUSINESS COMBINATION
PROPOSAL" shall mean, with respect to the Company, the commencement of
any tender or exchange offer, any bona fide, written proposal for a
merger, consolidation or other Business Combination involving the
shareholders of the Company, the Company or any Company Subsidiary or
any public announcement of a proposal, plan or intention to do any of
the foregoing. "BUSINESS COMBINATION" means any transaction which
contemplates (i) the acquisition of more than 35% of the assets of the
Company and the Company Subsidiaries taken as a whole or (ii) any other
agreement that contemplates the acquisition of beneficial ownership of
more than 35% of the outstanding shares of the Company's Common Stock.
"SUPERIOR PROPOSAL" shall mean, with respect to the Company, any
Business Combination Proposal, for which any required financing is
supported by reasonable commitments, that the Board of Directors of the
Company in good faith determines (after consultation with its financial
advisors) will be more favorable to its shareholders than the Merger.
(d) In addition to the obligations of the Company set forth in
SECTION 8.8(A) and SECTION 8.8(B), the Company shall promptly advise
Parent of any request for non-public written information or of any
Business Combination Proposal, or any inquiry with respect to or which
appears to be intended to or could reasonably be expected to lead to
any Business Combination Proposal, the material terms and conditions of
such request, Business Combination Proposal or inquiry, and in the case
of a Business Combination Proposal that involves consideration other
than all cash, the identity of the party making such Business
Combination Proposal. The Company shall keep Parent fully informed of
the status and details of any such request, Business Combination
Proposal or inquiry.
(e) During the period from the date of this Agreement through
the Effective Date, the Company shall not terminate, amend, modify or
waive any provision of any confidentiality or standstill agreement in
connection with a potential business combination to which it or any of
its Subsidiaries is a party. During such period, the Company shall use
commercially reasonable efforts to enforce, to the fullest extent
permitted under applicable law, the provisions of any such agreements
if and to the extent the executive officers of the Company have
knowledge of a breach of the terms thereof, including, but not limited
to, by obtaining injunctions to prevent any breaches of such agreements
and to enforce specifically the terms and provisions thereof in any
court of the United States of America or of any state having
jurisdiction.
Section 8.9 BONUS PAYMENTS. Immediately after the Effective Date and in
no event later than the first payment to a Holder pursuant to SECTION 3.2, the
Parent shall cause the Surviving Corporation to pay, on behalf of the Company,
(i) to Michael Puls, an amount equal to the Bonus (as defined in Paragraph 1 of
the Bonus Agreement, dated December 20, 1996 by and between the Company and
Michael Puls and amended by Paragraph 2 of the Amendment to Bonus Agreement,
dated April 2, 1998, and as further amended by a letter agreement dated May 15,
1998, each attached hereto as EXHIBIT E) and (ii) to Thomas Hoefert, an amount
equal to the Bonus (as defined in Paragraph 4 of the Bonus Agreement, dated
September 29, 1997 by and between the Company and Thomas Hoefert, attached
<PAGE>
32
hereto as EXHIBIT E). Together, the amounts paid to Michael Puls and Thomas
Hoefert pursuant to this SECTION 8.9 shall be referred to as the "EXECUTIVE
BONUS PAYMENTS."
Section 8.10 SIDE AGREEMENT. Simultaneously with the execution of this
Agreement, the parties hereto shall have executed and delivered to one another,
the Side Agreement, dated as of the date hereof, a copy of which is attached
hereto as EXHIBIT F.
Section 8.11 PREFERRED STOCK DESIGNATION. As soon as practicable after
the date hereof, but in no event later than five (5) business days after the
date the Preferred Stock Designation, attached hereto as EXHIBIT G, has been
approved by the California Secretary of State, the Company shall authorize and
issue preferred shares in form and substance substantially similar to the terms
of the Preferred Stock Designation, and the Parent or its designee shall
purchase such shares for $2,800,000. The Company shall grant customary demand
registration rights and "piggy back" rights to Parent or its designee upon the
reasonable request of Parent it being agreed that (i) fees and costs associated
with granting such rights shall be borne by Parent; and (ii) such rights will be
set forth in a registration rights agreement that the Company and Parent or its
designee will negotiate in good faith and enter into as soon as practicable
after the date hereof.
ARTICLE IX
CONDITIONS PRECEDENT
Section 9.1 CONDITIONS TO EACH PARTY'S OBLIGATION TO EFFECT THE MERGER.
The respective obligations of each party to effect the Merger shall be subject
to the fulfillment at or prior to the Effective Date of the following
conditions, any one or more of which may be waived (as permitted by law) in a
writing executed by Parent and the Company subject to and in accordance with
SECTION 10.4 hereof:
(a) This Agreement and the Merger shall have been approved and
adopted by the requisite vote of the holders of the Company Common
Stock.
(b) The waiting period under the HSR Act shall have expired or
been terminated; and no court or governmental authority or
instrumentality, domestic or foreign of competent jurisdiction (each a
"GOVERNMENTAL ENTITY") shall have enacted, issued, promulgated,
enforced or entered any law, statute, ordinance, rule, regulation,
judgment, decree, injunction or other order (whether temporary,
preliminary or permanent) that is in effect and restrains, enjoins or
otherwise prohibits consummation of the Merger (collectively, an
"ORDER").
Section 9.2 CONDITIONS TO OBLIGATION OF THE COMPANY TO EFFECT THE
MERGER. The obligation of the Company to effect the Merger shall be subject to
the fulfillment at or prior to the Effective Date of the following additional
conditions, unless waived in writing by the Company in accordance with SECTION
10.4 hereof:
(a) Parent and Sub shall have performed in all material
respects their agreements contained in this Agreement required to be
<PAGE>
33
performed on or prior to the Effective Date; and the Company shall have
received a certificate of Parent and Sub executed by a Vice President
of Parent and Sub, dated the Closing Date, to that effect.
(b) Each of the representations and warranties of Parent and
Sub contained in this Agreement (i) that is qualified by materiality or
Parent Material Adverse Effect shall be true and correct when made and
at and as of the Effective Date and (ii) that is not so qualified shall
be true and correct when made and at and as of the Effective Date
except where the failure of any such representations or warranties to
be so true and correct, individually or in the aggregate with other
such failures, would not have a Parent Material Adverse Effect (except
in the case of each of (i) and (ii) to the extent they expressly relate
to the date of this Agreement or any other particular date, in which
case, as of such date), and the Company shall have received a
certificate of Parent and Sub executed by a Vice President of Parent
and Sub, dated the Closing Date, to that effect.
Section 9.3 CONDITIONS TO OBLIGATIONS OF PARENT AND SUB TO EFFECT THE
MERGER. The obligations of Parent and Sub to effect the Merger shall be subject
to the fulfillment at or prior to the Effective Date of the following additional
conditions, unless waived in writing by Parent in accordance with SECTION 10.4
hereof:
(a) The Company shall have performed in all material respects
its agreements contained in this Agreement required to be performed on
or prior to the Effective Date; and Parent and Sub shall have received
a certificate of the Company executed by the Chief Executive Officer
and Chief Financial Officer of the Company, dated the Closing Date, to
that effect.
(b) Each of the representations and warranties of the Company
contained in this Agreement (i) that is qualified by materiality or
Company Material Adverse Effect shall be true and correct when made and
at and as of the Effective Date and (ii) that is not so qualified shall
be true and correct when made and at and as of the Effective Date
except where the failure of any such representations or warranties to
be so true and correct, individually or in the aggregate with other
such failures, would not have a Company Material Adverse Effect,
(except in the case and each of (i) and (ii) to the extent they
expressly relate to the date of this Agreement or any other particular
date, in which case, as of such date), and Parent and Sub shall have
received a certificate of the Company executed by the Chief Executive
Officer and Chief Financial Officer of the Company, dated the Closing
Date, to that effect.
(c) Parent shall have received opinions of counsel to the
Company, dated the Closing Date, substantially in form and substance
set forth in EXHIBIT H.
ARTICLE X
TERMINATION, AMENDMENT AND WAIVER
Section 10.1 TERMINATION. This Agreement may be terminated, and the
Merger abandoned, at any time prior to the Effective Date, whether before or
<PAGE>
34
after approval of the matters presented in connection with the Merger by the
shareholders of the Company or the shareholder of Sub:
(a) by mutual written consent of the Company, duly authorized
by its Board of Directors and Parent, duly authorized by any Vice
President;
(b) by Parent, by written notice to the Company, if (i) the
Company shall have failed to comply in any material respects with any
of its covenants or agreements contained in this Agreement required to
be complied with prior to the date of such termination, provided that
Parent is not then in material breach of any representation, warranty,
covenant or other agreement contained in this Agreement; provided
further that if such failure is curable by the Company prior to the
Termination Date (as defined below) through the exercise of its
reasonable efforts and for so long as the Company continues to exercise
such reasonable efforts, Parent may not terminate this Agreement under
this SECTION 10.1(B)(I), (ii) the shareholders of the Company shall not
approve the Merger at the Company Meeting or any adjournment thereof or
if a Company Meeting has not otherwise been called prior to the
Termination Date; or (iii) there has been (A) a material breach at the
time when made by the Company of any representation or warranty that is
not qualified as to materiality or (B) a breach at the time when made
by the Company of any representation or warranty that is qualified as
to materiality, provided that Parent is not then in material breach of
any representation, warranty, covenant or other agreement contained in
this Agreement; provided further that if such breach is curable by the
Company prior to the Termination Date through the exercise of its
reasonable efforts and for so long as the Company continues to exercise
such reasonable efforts, Parent may not terminate this Agreement under
this SECTION 10.1(B)(III);
(c) by the Company, by written notice to Parent, (i) if Parent
or Sub shall have failed to comply in any material respect with any of
its respective covenants or agreements contained in this Agreement
required to be complied with prior to the date of such termination,
provided that the Company is not then in material breach of any
representation, warranty, covenant or other agreement contained in this
Agreement; provided further that if such failure is curable by Parent
prior to the Termination Date through the exercise of its reasonable
efforts and for so long as Parent continues to exercise such reasonable
efforts, the Company may not terminate this Agreement under this
SECTION 10.1(2)(I), (ii) the shareholders of the Company shall not
approve the Merger at the Company Meeting or any adjournment thereof or
if a Company Meeting has not otherwise been called prior to the
Termination Date or (iii) there has been (A) a material breach at the
time when made by Parent or Sub of any representation or warranty that
is not qualified as to materiality or (B) a breach at the time when
made by Parent or Sub of any representation or warranty that is
qualified as to materiality; provided that the Company is not then in
material breach of any representation, warranty, covenant or other
agreement contained in this Agreement; provided further that if such
failure is curable by Parent prior to the Termination Date through the
exercise of its reasonable efforts and for so long as Parent continues
to exercise such reasonable efforts, the Company may not terminate this
Agreement under this SECTION 10.1(C)(III);
<PAGE>
35
(d) by either Parent or the Company, by written notice from
the terminating party to the other parties, if (i) the Merger has not
been effected on or prior to the close of business on, September 30,
1998 (the "TERMINATION DATE"); provided, that (A) the right to
terminate this Agreement pursuant to this clause (d) shall not be
available to any party whose willful and material failure to fulfill
any obligation of this Agreement has been the cause of, or resulted in,
the failure of the Merger to have occurred on or prior to such date and
(B) if Parent has given notice to the Company, or the Company has given
notice to Parent, pursuant to SECTIONS 8.7(B)(I)(A) or 8.7(B)(I)(B)
with respect to any inaccuracy or failure on the part of the other,
after September 20, 1998, the Termination Date shall automatically be
extended by the number of days necessary to provide the party so
notified with 10 days in which to effect a cure as permitted in
SECTIONS 10.1(B)(I); 10.1(B)(III), SECTION 10.1(C)(I) and 10.1(C)(III)
or (ii) any court or other Governmental Entity having jurisdiction over
a party hereto shall have issued an order, decree or ruling or taken
any other action permanently enjoining, restraining or otherwise
prohibiting the transactions contemplated by this Agreement and such
order, decree, ruling or other action shall have become final and
nonappealable, provided the terminating party shall have complied with
its obligations under SECTION 8.7; or (iii) any order or directive that
does not directly enjoin or otherwise prohibit the consummation of the
transactions contemplated by this Agreement, but that would, if Parent
or the Company were to comply with such order or directive as a
condition to consummating the transactions contemplated hereby, have a
material adverse effect on the business, operations or financial
condition of the Surviving Corporation and such order or directive has
become final and nonappealable, provided the terminating party shall
have used all reasonable efforts to remove such order or directive;
(e) by the Company by written notice to Parent if the Board of
Directors of the Company reasonably determines that a Business
Combination Proposal is a Superior Proposal (and the Company has
complied with its obligations under SECTION 8.8(B));
(f) by Parent, by written notice to the Company, if (i) the
Board of Directors of the Company shall have failed to recommend the
Merger to Company's shareholders, or shall have modified in a manner
adverse to Parent or withdrawn its recommendation of the Merger to the
Company's shareholders as being advisable and fair to and in the best
interests of the Company and its shareholders, or shall have modified
in a manner adverse to Parent or withdrawn its approval of this
Agreement or (ii) the Board of Directors of the Company shall have
recommended to the shareholders of the Company any Business Combination
Proposal or shall have resolved to do so; provided that any disclosure
that the Board of Directors of the Company is compelled to make of the
receipt of Business Combination Proposal in order to comply with its
fiduciary duties or Rule 14d-9 or 14e-2 shall not in and of itself
constitute the modification or rescission of the Board's
recommendation; provided, further, that such disclosure states that no
action will be taken by the Board with respect to the withdrawal of its
recommendation of the transactions contemplated hereby or the approval
or recommendation of any Business Combination Proposal except in
accordance with SECTION 8.8.
<PAGE>
36
The right of Parent or the Company to terminate this Agreement pursuant
to this SECTION 10.1 shall remain operative and in full force and effect
regardless of any investigation made by or on behalf of such party, whether
prior to or after the execution of this Agreement.
Section 10.2 EFFECT OF TERMINATION. In the event of the termination of
this Agreement by either Parent or the Company as provided in SECTION 10.1, this
Agreement shall become void without any liability hereunder on the part of the
Company, Parent, Sub or their respective directors or officers, except for the
next to last sentence of SECTION 8.1, SECTION 8.4(H), this SECTION 10.2, SECTION
11.3 and 11.8, which shall survive any such termination, unless such termination
results from the willful and material breach by a party of any of its covenants
or other agreements set forth in this Agreement or the material breach with
fraudulent purpose at the time made by a party of any of its representations and
warranties, in which event the terminating party shall retain its rights and
remedies against such other party in respect of such other party's breach.
Section 10.3 AMENDMENT. This Agreement may be amended by the parties
hereto, by or pursuant to action taken by their respective Boards of Directors
(or committee thereof) in the case of the Company and Sub and by any Vice
President in the case of Parent, at any time before or after approval hereof by
the shareholders of the Company, but, after such approval, no amendment shall be
made that under applicable law requires further approval of such shareholders
without such further approval. This Agreement may not be amended except by an
instrument in writing signed on behalf of each of the parties hereto.
Section 10.4 WAIVER. At any time prior to the Effective Date, the
parties hereto, by or pursuant to action authorized by their respective Boards
of Directors (or committee thereof) in the case of the Company and Sub and by
any Vice President in the case of Parent, may, as permitted by law, (i) extend
the time for the performance of any of the obligations or other acts of the
other parties hereto, (ii) waive any inaccuracies in the representations and
warranties of any other party contained herein or in any documents delivered
pursuant hereto by any other party and (iii) waive compliance with any of the
agreements or conditions contained herein. Any agreement on the part of a party
hereto to any such extension or waiver shall be valid if set forth in an
instrument in writing signed on behalf of such party.
ARTICLE XI
GENERAL PROVISIONS
Section 11.1 NON-SURVIVAL OF REPRESENTATIONS, WARRANTIES AND
AGREEMENTS. All representations and warranties set forth in this Agreement shall
terminate at the earlier of (x) the Effective Date and (y) except as provided in
SECTION 10.2 hereof, termination of this Agreement in accordance with ARTICLE X
hereof. All covenants and agreements set forth in this Agreement shall survive
in accordance with their terms.
Section 11.2 NOTICES. All notices or other communications under this
Agreement shall be in writing and shall be given (and shall be deemed to have
been duly given upon receipt) by delivery in person, by facsimile transmission
<PAGE>
37
or by delivery service (with confirmation of receipt obtained), or by registered
or certified mail, postage prepaid, return receipt requested, addressed as
follows:
If to the Company:
InnoServ Technologies, Inc.
320 Westway, Suite 520
Arlington, Texas 76018
Telecopy No.: 817-472-2926
Attn: Michael Puls
With a copy to:
Gibson, Dunn & Crutcher LLP
1717 Main Street, Suite 5400
Dallas, Texas 75201
Telecopy No.: 214-698-3400
Attn: Stephen C. Johnson
If to Parent or Sub:
General Electric Company
c/o GE Medical Systems
3000 North Grandview Boulevard
Waukesha, Wisconsin 53188
Telecopy No.: 414-544-3573
Attn: General Counsel
or to such other address as any party may have furnished to the other parties in
writing in accordance with this SECTION 11.2.
Section 11.3 EXPENSES.
(a) If the Merger shall not be consummated for any reason
other than as a result of this Agreement having been terminated
pursuant to Sections 10.1(b), 10.1(c)(ii), 10.1(e) or 10.1(f), Parent
hereby agrees to pay to the Company the lesser of (A) the Company's
legal fees and expenses associated with (1) any such filings and
compliance with the HSR Act, and (2) the preparation and review of the
letter of intent associated with this Agreement, or (B) $75,000.
(b) Except as otherwise provided in this SECTION 11.3, whether
or not the Merger shall be consummated, all costs and expenses incurred
in connection with this Agreement and the transactions contemplated
hereby, including, without limitation, the fees and disbursements of
counsel, financial advisors, accountants, actuaries and consultants,
shall be paid by the party incurring such costs and expenses.
<PAGE>
38
(c) Notwithstanding any provision in this Agreement to the
contrary, provided that Parent or Sub is not then in material breach of
its obligations under this Agreement, if this Agreement shall have been
terminated pursuant to SECTIONS 10.1(B), 10.1(C)(II), 10.1(E) OR
10.1(F), the Company shall within 90 days of such termination pay to
Parent an amount in cash equal to $550,000.
Section 11.4 PUBLICITY. The initial press release concerning this
Agreement and the transactions contemplated hereby shall be a press release from
the Company (as agreed to by the Company and Parent) and thereafter, except as
may be required by law or by obligations pursuant to any listing agreement with
or rules of any national securities exchange or quotation service, so long as
this Agreement is in effect, Parent, Sub and the Company agree to consult with
each other in issuing any press release or otherwise making any public statement
with respect to the transactions contemplated by this Agreement, and none of
them shall issue any press release or make any public statement prior to such
consultation. The commencement of litigation relating to this Agreement or the
transactions contemplated hereby or any proceedings in connection therewith
shall not be deemed a violation of this SECTION 11.4.
Section 11.5 INTERPRETATION. The headings contained in this Agreement
are for reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement.
Section 11.6. OBLIGATIONS OF PARENT AND OF THE COMPANY. Whenever this
Agreement requires Sub or a Parent Subsidiary to take any action, such
requirement shall be deemed to constitute an undertaking on the part of Parent
to cause Sub or such Parent Subsidiary to take such action. Whenever this
Agreement requires a Company Subsidiary to take any action, such requirement
shall be deemed to constitute an undertaking on the part of the Company to cause
such Company Subsidiary to take such action and, after the Effective Date, on
the part of the Surviving Corporation to cause such Company Subsidiary to take
such action.
Section 11.7. SEVERABILITY. The provisions of this Agreement shall be
deemed severable and the invalidity or unenforceability of any provision shall
not affect the validity or enforceability or the other provisions hereof. If any
provision of this Agreement, or the application thereof to any Person or any
circumstance, is invalid or unenforceable, (a) a suitable and equitable
provision shall be substituted therefor in order to carry out, so far as may be
valid and enforceable, the intent and purpose of such invalid or unenforceable
provision and (b) the remainder of this Agreement and the application of such
provision to other Person or circumstances shall not be affected by such
invalidity or unenforceability, nor shall such invalidity or unenforceability
affect the validity or enforceability of such provision, or the application
thereof, in any other jurisdiction.
Section 11.8 MISCELLANEOUS. This Agreement (together with the exhibits, the
Company Disclosure Schedule and the Parent Disclosure Schedule referred to
herein) and the Confidentiality Agreement (i) constitute the entire agreement
and supersede all other prior agreements and understandings, both written and
oral, among the parties, or any of them, with respect to the subject matter
hereof, (ii) except as provided in SECTION 8.5, is not intended to confer upon
any other person any rights or remedies hereunder and shall be binding upon and
inure to the benefit solely of each party hereto, and their respective
successors and assigns, (iii) shall not be assigned by operation of law or
<PAGE>
39
otherwise, except that Sub shall have the right to assign to any direct wholly
owned subsidiary of Parent incorporated under the laws of California any and all
rights and obligations of Sub under this Agreement and Parent guarantees the
full and punctual performance of all of the obligations hereunder of Sub and any
such assignees; (iv) shall be governed in all respects, including validity,
interpretation and effect, by the laws of the State of New York (except to the
extent the laws of the State of California may mandatorily apply). The parties
hereby irrevocably submit to the jurisdiction of the courts of the State of New
York and the Federal courts of the United States of America located in the
Southern District, State of New York, solely in respect of the interpretation
and enforcement of the provisions of this Agreement and of the documents
referred to in this Agreement, and in respect of the transactions contemplated
hereby, and hereby waive, and agree not to assert, as a defense in any action,
suit or proceeding for the interpretation or enforcement hereof or any of such
document, that it is not subject thereto or that such action, suit or proceeding
may not be brought or is not maintainable in said courts or that the venue
thereof may not be appropriate or that this Agreement or any such document may
not be enforced in or by such courts, and the parties hereto irrevocably agree
that all claims with respect to such action or proceeding shall be heard and
determined in such a New York State or Federal court. The parties hereby consent
to and grant any such court jurisdiction over the person of such parties and
over the subject matter of such dispute and agree that mailing of process or
other papers in connection with any such action or proceeding in the manner
provided in SECTION 11.2 or in such other manner as may be permitted by law
shall be valid and sufficient service thereof. EACH PARTY ACKNOWLEDGES AND
AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO
INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY
IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL
BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR
RELATING TO THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.
EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR
ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH
OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING
WAIVER, (B) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS
WAIVER, (C) EACH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (D) EACH PARTY HAS
BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL
WAIVERS AND CERTIFICATIONS IN THIS SECTION 11.8. This Agreement may be executed
in any number of counterparts which together shall constitute a single
agreement.
EXHIBIT 99(B)
CERTIFICATE OF DETERMINATION OF SERIES B PREFERRED STOCK
OF
INNOSERV TECHNOLOGIES, INC.
----------------------
Pursuant to Sections 400 & 401 of the
General Corporation Law of the
State of California
----------------------
I, Michael Puls, President and Tom Hoefert, Assistant Secretary of
InnoServ Technologies, Inc., a corporation organized and existing under the
General Corporation Law of the State of California (the "Company"), in
accordance with the provisions of Section 401 thereof, HEREBY CERTIFY:
That pursuant to the authority conferred upon the Board of Directors of
the Company (the "Board") by the Articles of Incorporation of the Company, the
Board duly adopted the following resolution designating a Series B of Preferred
Stock consisting of 700,000 shares, none of which has been issued as of the date
of this Certificate of Determination:
RESOLVED, that pursuant to the authority vested in the Board in
accordance with the provisions of the Articles of Incorporation of the Company,
a Series B of Preferred Stock of the Company be and hereby is created, and that
the designation and number of shares of such series and the voting powers,
preferences and relative, optional and other rights of the shares thereof, and
the qualifications, limitations and restrictions thereof, are as follows:
SERIES B PREFERRED STOCK.
1. DESIGNATION, AMOUNT AND RANKING.
(a) DESIGNATION AND AMOUNT. The shares of the series created in this
resolution shall be designated as "Series B Preferred Stock" (the "Series B
Preferred Stock") and the number of shares constituting such series shall be
Seven Hundred Thousand (700,000).
(b) RANKING. With regard to rights to receive dividends, rights to
distributions of assets upon liquidation, dissolution or winding up of the
affairs of the Company, and rights to payment upon redemption, the Series B
Preferred Stock shall rank senior and prior in right to (i) the Common Stock,
par value $.01 per share, of the Company as constituted on the date of this
Certificate of Designation or as such stock may be reconstituted from time to
time after such date (the "Common Stock"), and (ii) as to any other series of
Preferred Stock, as established by the Board.
2. DIVIDENDS.
(a) ACCRUAL OF DIVIDENDS. The holders of the Series B Preferred Stock
shall have no right to receive dividends except as provided in this Section 2.
Each holder of a share of Series B Preferred Stock shall be entitled to receive,
when declared by the Board, out of the funds of the Corporation legally
available therefor pursuant to the California General Corporation Law ("Legally
Available Funds"), cumulative dividends in cash in the amount of $0.32 per share
per annum. Such dividends shall accrue from day to day, beginning six (6) months
from the date of issuance of such share, whether or not earned or declared, and
shall be due and payable semi-annually on the last day of each June, and
December, beginning the last day of December 1998; provided that whenever any
such payment date is a Saturday, Sunday or public or bank holiday or the
equivalent for banks generally under the laws of the State of Texas (any other
day being a "business day"), such dividends may be paid on the next succeeding
business day (the day on which such payment is to be made, a "Dividend Payment
Date"). Any such dividends not paid when due or otherwise not thereafter paid as
set forth in Section 2(b) shall become part of the Liquidation Value except with
respect to such dividends with respect to shares that are converted pursuant to
Section 6, which dividends shall be payable pursuant to Section 6(b).
(b) OTHER DIVIDENDS. Other than dividends of Common Stock on the Common
Stock, no dividend or other distribution shall be paid, or declared and set
apart for payment, on the shares of any class or series of capital stock of the
Company, unless any accrued but unpaid dividends owed to holders or former
holders Series B Preferred Stock are first paid in full pursuant to Sections
2(a) or 6(b) and the outstanding shares of Series B Preferred Stock are included
in such dividend or distribution PARI PASSU to the shares of capital stock of
the Company to which the dividend or distribution is being paid or declared with
respect to, by applying the Conversion Ratio (as hereinafter defined in Section
6) to such shares of Series B Preferred Stock as if such shares had been
converted immediately prior to the record date of such dividend or distribution.
3. LIQUIDATION.
(a) PREFERENCE. In the event of any voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, after
payment or provision for payment of the debts and other liabilities of the
Company and payment or provision for payment of any class or series of capital
stock of the Company ranking as to assets senior to the Series B Preferred Stock
then outstanding, the holder of each share of Series B Preferred Stock shall be
entitled to receive out of the assets of the Company, whether such assets are
capital, surplus or earnings, an amount equal to the Liquidation Value (as
hereinafter defined) of such share before any payment shall be made or assets
distributed on the Common Stock or any other class or series of capital stock of
the Company ranking as to assets junior to the Series B Preferred Stock. After
payment to the holders of Series B Preferred Stock of the amounts to which such
holders are entitled as set forth in this Section 3(a), the holders of the
Series B Preferred Stock shall have no claim, in their capacity as holders, to
any of the remaining assets of the Company.
(b) PARTIAL PAYMENT. If upon any dissolution, liquidation or winding up
of the affairs of the Company, the assets of the Company distributable among the
holders of the Series B Preferred Stock shall be insufficient to permit the
payment to them of the full preferential amounts to which they are entitled,
then the entire assets of the Company so to be distributed shall be distributed
ratably among the holders of the Series B Preferred Stock.
(c) REMAINING ASSETS After payment or distribution to the holders of
the Series B Preferred Stock of the full amounts set forth in Section 3(a), the
holders of the Common Stock and any other class or series of capital stock of
the Company ranking as to assets junior to the Series B Preferred Stock then
outstanding shall be entitled to receive in accordance with their respective
preferences and, in the absence thereof, ratably all remaining assets of the
Company to be distributed.
(d) REORGANIZATION. For the purposes of this Section 3, a liquidation,
dissolution or winding up of the affairs of the Company shall not be deemed to
be occasioned by or to include any Reorganization. For the purposes of this
Agreement, a "Reorganization" shall mean any of, or any combination of, a
capital reorganization, any reclassification of the Common Stock (other than a
change in par value or as a result of a stock dividend, subdivision, split-up or
combination of shares), the consolidation or merger of the Company with or into
another person, any agreement or arrangement (including any tender offer) that
contemplates the acquisition of beneficial ownership of more than 35% of the
outstanding shares of the Company's Common Stock, or the sale or other
disposition of all or substantially all of the property and assets of the
Company to another person.
(e) LIQUIDATION VALUE. The "Liquidation Value" per share of the Series
B Preferred Stock as of any particular date shall be the sum of (i) $4.00 plus
(ii) all accrued but unpaid dividends as of such date.
4. REDEMPTION.
(a) OPTIONAL REDEMPTION. To the extent the Company shall have Legally
Available Funds therefor, the Company shall have the right, but not the
obligation, to redeem all, or any portion thereof, of the shares of Series B
Preferred Stock outstanding at any time after the date of the issuance thereof
at a redemption price per share equal to the Liquidation Value thereof at such
date; provided, that the holder of such shares shall have the right, at such
holder's option, to exercise such holder's conversion rights granted under
Section 6 hereof, if applicable, prior to the applicable redemption date.
(b) REORGANIZATION REDEMPTION. The Company shall notify each of the
holders of Series B Preferred Stock as soon as practicable after, but in no
event later than ten (10) days after the consummation of a Reorganization.
Within twenty (20) days of such notice from the Company, each of the holders of
Series B Preferred Stock shall, at any such holder's option, have the right to
cause the Company to redeem all, and not less than all, of the outstanding
Series B Preferred Stock held by such holder at a price per share equal to the
Liquidation Value thereof.
(c) MANDATORY REDEMPTION. On May 19, 2008 (or if not a business day on
the next business day after May 19, 2008), the Company shall redeem, to the
extent the Company shall have Legally Available Funds therefor, all shares of
Series B Preferred Stock then outstanding at the close of business upon such
date at a redemption price per share equal to the Liquidation Value thereof at
such date.
(d) PAYMENT OF REDEMPTION PRICE. For each share of Series B Preferred
Stock which is to be redeemed, the Company shall be obligated, on the applicable
redemption date to pay to the holder thereof (upon surrender by such holder at
the Company's office of the certificate representing such share) the applicable
redemption price thereof. If the Company lacks Legally Available Funds for
redemption of shares of Series B Preferred Stock on any such redemption date
required to redeem the total number of shares to be redeemed on such date, the
maximum possible number of shares shall be redeemed to the extent of Legally
Available Funds ratably among the holders of the shares to be redeemed based
upon the aggregate applicable redemption price of such shares held by each such
holder. At any time thereafter if Legally Available Funds become available for
the redemption of shares of Series B Preferred Stock, such funds will
immediately be used to redeem the balance of the shares which the Company has
become obligated to redeem on any such redemption date but which it has not
redeemed.
(e) NOTICE OF REDEMPTION; REDEMPTION DATE.
(i) In the case of a redemption pursuant to Section 4(a), the
Company shall provide written notice of each redemption of Series B
Preferred Stock to each record holder thereof not less than five (5)
business days prior to the applicable redemption date, stating the date
and place of redemption, the applicable redemption price and the number
of shares held by such holder to be redeemed.
(ii) In the case of a redemption pursuant to Section 4(b), the
Company shall cause the redemption date to occur not more than five (5)
business days after notice of a demand for redemption is received by
the Company from the holder.
(iii) In the case of a redemption pursuant to Section 4(c),
the Company shall provide written notice of each redemption of Series B
Preferred Stock to each record holder thereof not more than sixty (60)
nor less than thirty (30) days prior to the applicable redemption date,
stating the date and place of redemption, the applicable redemption
price and the number of shares held by such holder to be redeemed.
(f) EFFECT OF REDEMPTION. If notice of redemption shall have been given
by the Company as provided in Section 4(d), and if on or before such redemption
date the aggregate redemption price of the shares to be redeemed which shall not
have theretofore been converted as provided in Section 6 shall have been set
aside by the Company in a separate account so as to be available for the
redemption of such shares, then such shares, whether or not the certificates
therefor shall have been surrendered for redemption, shall be deemed no longer
outstanding for any purpose and all rights of the holders with respect to such
shares shall thereupon cease and terminate, except only if not so converted, the
right to receive out of the funds so set aside such redemption price, without
interest, upon endorsement, if required, and surrender by the holders of their
certificates for such shares.
5. VOTING RIGHTS. Except as otherwise expressly provided by law, shares of
Series B Preferred Stock shall not have any right to vote for the election of
directors or for any other purpose, and said shares shall not be entitled to any
notice of any meeting of stockholders of the Company.
6. CONVERSION. The rights of the holders of shares of Series B Preferred
Stock to convert such shares into shares of Common Stock and the terms and
conditions of such conversion shall be as follows:
(a) RIGHT TO CONVERT. Each share of Series B Preferred Stock shall be
convertible, at the option of the holder thereof, at any time after the earlier
of (i) payment of all amounts due to the Company pursuant to that certain
agreement referenced in Section 8.10 of the Agreement and Plan of Merger, dated
May 19, 1998, ("the Merger Agreement") by and among General Electric Company,
Diamond Merger Sub, Inc., and the Company, or (ii) the later of (A) September
30, 1998 or (B) termination of the Merger Agreement, and prior to the applicable
redemption date therefor (unless the Company shall fail to pay or provide for
the payment of the applicable redemption price in respect thereof), at the
office of the Company or any transfer agent for the Series B Preferred Stock or
the Common Stock, into the number of the fully paid and nonassessable shares of
Common Stock determined in accordance with Section 6. In order to convert shares
of the Series B Preferred Stock into shares of Common Stock, the holder thereof
shall surrender the certificate or certificates therefor, duly endorsed, at the
office of the Company or to the transfer agent for the Series B Preferred Stock
or the Common Stock, together with written notice to the Company stating that
such holder elects to convert the same and setting forth the name or names in
which such holder wishes the certificate or certificates for Common Stock to be
issued, and the number of shares of Series B Preferred Stock being converted.
(b) CONVERSION MECHANICS. The Company shall, as soon as practicable
after the surrender of the certificate or certificates evidencing shares of
Series B Preferred Stock for conversion at the office of the Company or the
transfer agent for the Series B Preferred Stock or the Common Stock, issue to
each holder of such shares, or such holder's nominee or nominees, a certificate
or certificates evidencing the number of shares of Common Stock (and any other
securities and property) to which such holder shall be entitled and, in the
event that only a part of the shares evidenced by such certificate or
certificates is converted, a certificate evidencing the number of shares of
Series B Preferred Stock which are not converted. A conversion shall be deemed
to have been effective immediately prior to the close of business on the date
the holder surrenders its shares of Series B Preferred Stock to be converted, so
that, with respect to such conversion, except with respect to the rights set
forth in the last sentence of this Section 6(b), the rights of the holder of
such shares of Series B Preferred Stock as such shall cease at the effective
time of such conversion and the person or persons entitled to receive the shares
of Common Stock issuable upon such conversion shall be treated for all purposes
as the record holder or holders of such shares of Common Stock at such time. If
the last day for the exercise of the right of conversion shall not be a business
day such conversion right may be exercised on the next succeeding business day.
Upon any conversion of Series B Preferred Stock, to the extent there are any
accrued but unpaid dividends due and owing the holders of such Series B
Preferred Stock so converting, the Company shall, within one (1) year from the
date of such conversion, pay to such converting holders the full amount of such
accrued but unpaid dividends, with interest accumulating at the rate of eight
percent (8%) per annum, from the date of such conversion; and provided that the
restrictions set forth in Section 2(b) shall survive until such declaration and
payment.
(c) CONVERSION RATIO. Subject to Sections 6(d) and 6(e), each share of
Series B Preferred Stock shall be convertible into one (1) share of Common Stock
(the "Conversion Ratio").
(d) ADJUSTMENT FOR STOCK SPLITS AND COMBINATIONS. If outstanding shares
of the Common Stock shall be subdivided into a greater number of shares, or a
dividend in Common Stock or other securities of the Company convertible into or
exchangeable for Common Stock (in which latter event the number of shares of
Common Stock issuable upon the conversion or exchange of such securities shall
be deemed to have been distributed), shall be paid in respect to the Common
Stock, the Conversion Ratio in effect immediately prior to such subdivision or
at the record date of such dividend shall, simultaneously with the effectiveness
of such subdivision or immediately after the record date of such dividend, be
proportionately increased, and conversely, if outstanding shares of the Common
Stock shall be combined into a smaller number of shares, the Conversion Price in
effect immediately prior to such combination shall simultaneously with the
effectiveness of such combination, be proportionately reduced.
(e) REORGANIZATION. In the event that the Company shall propose or be
subject to a Reorganization, the Company shall give five (5) business days
written notice to holders of Series B Preferred Stock prior to such
Reorganization. In the event of a Reorganization, the holders of the Series B
Preferred Stock shall thereafter be entitled to receive upon conversion of the
Series B Preferred Stock the kind and number of shares of Common Stock or other
securities or property (including cash) of the Company, or other corporation
resulting from such consolidation or surviving such merger or to which such
property and assets shall have been sold or otherwise disposed of, to which a
holder of the number of shares of the Common Stock into which the Series B
Preferred Stock was convertible immediately prior to such Reorganization would
have been entitled to receive (together with any accrued but unpaid dividends
owed to holders of Series B Preferred Stock pursuant to Section 2(a), as payable
pursuant to Section 6(b)); and in any such case appropriate adjustment shall be
made by the Board in the application of the provisions herein set forth with
respect to the rights and interests thereafter of the holders of the Series B
Preferred Stock, to the end that the provisions set forth herein (including the
specified changes and other adjustments to the Conversion Ratio) shall
thereafter be applicable, as nearly as reasonably may be, in relation to any
shares, other securities or property thereafter receivable upon conversion of
the Series B Preferred Stock. The provisions of this Section 6(e) shall
similarly apply to successive Reorganizations.
(f) CERTIFICATE OF ADJUSTMENT. In each case of an adjustment or
readjustment of the Conversion Ratio or the number of shares of Common Stock or
other securities or property deliverable upon conversion of the Series B
Preferred Stock, the Company shall compute such adjustment or readjustment in
accordance with this Section 6, prepare a certificate showing such adjustment or
readjustment, and mail such certificate to each registered holder of Series B
Preferred Stock at the holder's address as shown on the books of the Company.
The certificate shall set forth such adjustment or readjustment, showing the
facts upon which such adjustment or readjustment is based, including a statement
of (i) the Conversion Ratio at the time in effect and (ii) the type and amount,
if any, of other securities or property which at the time would be received upon
conversion of the Series B Preferred Stock. Such notice may be given in advance
of such adjustment or readjustment and may be included as part of a notice
required to be given pursuant to Section 6(g).
(g) NOTICES OF RECORD DATE. In the event the Company shall propose to
take any action of the type or types requiring an adjustment to the Conversion
Ratio or the number, kind or class of shares or other securities or property
into which the Series B Preferred Stock shall be convertible pursuant to this
Section 6, the Company shall give five (5) business days' prior written notice
to the holders of the Series B Preferred Stock in the manner set forth in
Section 6(f), which notice shall specify the record date, if any, with respect
to any such action and the date on which such action is to take place. Such
notice shall also set forth such facts with respect thereto as shall be
reasonably necessary to indicate the effect of such action (to the extent such
effect may be known at the date of such notice) on the Conversion Ratio and the
number, kind or class of shares or other securities or property which shall be
deliverable upon the occurrence of such action or deliverable upon the
conversion of the Series B Preferred Stock. The omission or delay in giving such
notice shall not affect the validity or effectiveness of such action.
(h) RESERVATION OF STOCK ISSUABLE UPON CONVERSION. The Company shall at
all times reserve and keep available out of its authorized but unissued shares
of Common Stock, solely for the purpose of effecting the conversion of the
shares of Series B Preferred Stock, such number of its shares of Common Stock as
shall from time to time be sufficient to effect a conversion of all outstanding
shares of the Series B Preferred Stock, and if at any time the number of
authorized but unissued shares of Common Stock shall not be sufficient to effect
the conversion of all then outstanding shares of the Series B Preferred Stock,
the Company shall promptly seek such corporate action as may, in the opinion of
its counsel, be necessary to increase its authorized but unissued shares of
Common Stock to such number of shares as shall be sufficient for such purpose.
(i) PAYMENT OF TAXES. The Company shall pay all taxes and other
governmental charges (other than any income or other taxes imposed upon the
profits realized by the recipient) that may be imposed in respect of the issue
or delivery of shares of Common Stock or other securities or property upon
conversion of shares of Series B Preferred Stock; provided, however, that the
Company shall not be required to pay any tax or other governmental charge which
may be payable in respect of any transfer involved in the issue or delivery of
any certificate in a name other than that of the holder of the Series B
Preferred Stock converted, and the Company shall not be required to issue or
deliver such certificate unless and until the person or persons requesting the
issuance thereof shall have paid to the Company the amount of such tax or other
governmental charge or shall have established to the satisfaction of the Company
that such tax or other governmental charge has been paid.
(j) SURRENDERED SHARES. All certificates representing Series B
Preferred Stock surrendered for conversion or redeemed shall be appropriately
canceled on the books of the Company, and the shares so converted represented by
such certificates shall be restored to the status of authorized but unissued
shares of Preferred Stock of the Company.
EXHIBIT 99(C)
REGISTRATION RIGHTS AGREEMENT
BETWEEN
INNOSERV TECHNOLOGIES, INC.
AND
NATIONAL MEDICAL DIAGNOSTICS, INC.
DATED AS OF
JUNE 4, 1998
<PAGE>
REGISTRATION RIGHTS AGREEMENT
This Registration Rights Agreement (this "Agreement") is
entered into as of the 4th day of June, 1998, between National Medical
Diagnostics, Inc., a Delaware corporation (the "Investor"), and InnoServ
Technologies, Inc., a California corporation (the "Company").
PRELIMINARY STATEMENTS:
WHEREAS, General Electric Company ("GE"), Diamond Merger Sub,
Inc., and the Company are parties to an agreement and plan of merger dated as of
May 19, 1998 (the "Merger Agreement").
WHEREAS, the Merger Agreement provides that GE (or its
designee) shall purchase for $2,800,000, and the Company shall deliver to GE (or
its designee), 700,000 shares of a newly created Series B Preferred Stock, par
value $.01 per share, of the Company ("Series B") within five business days
after the designation for such Series B has been approved by the Secretary of
State of the State of California.
WHEREAS, such designation has been so approved, GE has
designated the Investor as the person to purchase such Series B, the Investor
has purchased such Series B and the Company has delivered to the Investor such
Series B.
WHEREAS, the Merger Agreement provides that the Company and GE
(or its designee) will enter into a registration rights agreement in which the
Company will grant certain registration rights to GE (or its designee).
TERMS AND CONDITIONS:
NOW THEREFORE, the Investor and the Company agree as follows:
ARTICLE I
REGISTRATION RIGHTS
1.1 PIGGYBACK REGISTRATION RIGHTS.
(a) RIGHT TO PIGGYBACK. Subject to the limitations set forth
in Section 1.1(e) hereof, whenever the Company proposes to file a registration
statement (a "Proposed Registration") under the Securities Act of 1933, as
amended (the "Securities Act"), with respect to any equity security (as defined
in the Securities Act) (other than a registration statement on Form S-4, Form
S-8 or any successor form for the registration of securities to be offered in a
transaction subject to Rule 145 under the Securities Act or to employees of,
and/or consultants and advisors to, the Company and/or its subsidiaries pursuant
to any "employee benefit plan," as such term is defined in Rule 405 promulgated
under the Securities Act) and the registration form to be used may be used for
the registration (the "Piggyback Registration") of Piggyback Registrable
Securities, the Company will give written notice (the "Piggyback Notice") to the
Investor as soon as practicable (but in no event less than 45 days) before the
initial filing with the SEC of such registration statement, which notice shall
(i) specify the kind and number of securities proposed to be registered and the
proposed offering price or prices and distribution arrangements; (ii) include
such other information that at the time and under the circumstances would be
appropriate to include in such notice; and (iii) subject to the provisions of
Section 1.1(e), offer the Investor the opportunity to include in such filing all
Piggyback Registrable Securities which the Investor may request in accordance
with subsection 1.1(b) below. "Piggyback Registrable Securities" shall mean any
shares of common stock of the Company, par value $.01 (the "Common Stock"),
receivable by Investor as a result of the conversion and anti-dilution rights
pertaining to the Series B.
(b) REQUESTS TO PIGGYBACK. The Investor shall advise the
Company in writing (a "Piggyback Registration Request") within 15 days after the
date of receipt of the Piggyback Notice of the number or amount of each class or
series of Piggyback Registrable Securities which the Investor desires to have
registered.
(c) SELECTION OF UNDERWRITERS. If the Piggyback Registration
is an underwritten offering, the Board of Directors of the Company will select a
managing underwriter or underwriters to administer the offering, who shall be
reasonably satisfactory to the Investor.
(d) PIGGYBACK EXPENSES. Subject to the limitations set forth
in Section 1.3(d) hereof, all Registration Expenses (as defined in Section
1.3(d)) of the Piggyback Registration will be paid by the Investor.
(e) LIMITATIONS ON PIGGYBACK RIGHTS. The Investor will be
entitled to an unlimited number of Piggyback Registrations. The exercise of a
Piggyback Registration shall not affect the Investor's Demand Registration
rights under Section 1.2 hereof. The Investor shall not be permitted to exercise
its Piggyback Registration rights with regard to any underwritten Piggyback
Registration where a first or second tier underwriter, or underwriters, provides
the Investor with an opinion that the amount or kind of the Investor's shares to
be included in such offering would adversely affect the success of the
securities proposed to be distributed for the account of the Company in such
offering. However, the Investor shall be entitled to include all of its
Piggyback Registrable Securities in any such Piggyback Registration before any
other securities which are entitled to be registered pursuant to the exercise of
contractual rights comparable to the rights granted in this Section 1.1.
1.2 DEMAND REGISTRATION RIGHTS.
(a) REQUESTS FOR REGISTRATION. Subject to the limitations set
forth in Section 1.2(d), at any time after the Investor has the right to convert
the Series B to Common Stock pursuant to the Series B designation, the Investor
may request the Company to register under the Securities Act all or part of its
Demand Registrable Securities on Form S-1, Form S-3 or any other registration
form available for use by the Company (a "Demand Registration"). The request for
a Demand Registration (the "Demand Notice") shall specify the number of Demand
Registrable Securities requested to be registered and the anticipated per share
price range for such offering. However, the Company may postpone, for a
reasonable period of time not to exceed 90 days (but in any event not to extend
beyond the date of public disclosure of the information, or the date of
abandonment or termination of the transactions or negotiations, hereinafter
referred to), the filing of a registration statement otherwise required to be
prepared and filed by it pursuant to this subsection 1.2(a) if (i) at the time
the Company receives a Demand Notice, the Board of Directors of the Company
determines, in good faith and in its reasonable business judgment, that (A) such
Demand Registration would require the public disclosure of material non-public
information concerning any pending or ongoing material transaction or
negotiations involving the Company which, in the opinion of the Company's
outside legal counsel, is not yet required to be publicly disclosed, and (B)
such disclosure would materially interfere with such transaction or negotiations
or have a material adverse effect on the Company, and (ii) the Company
diligently and in good faith continues to pursue such transaction or
negotiations throughout the period of such postponement. The Company may not
postpone a Demand Registration pursuant to this Section 1.2(a) more than once in
any 12-month period.
"Demand Registrable Securities" means, the Series B and any
other shares of Common Stock received by the Investor as a result of the
conversion and anti-dilution rights pertaining to the Series B.
(b) SELECTION OF UNDERWRITERS. If the Demand Registration is
for or includes an underwritten offering, the Investor shall select the managing
underwriter or underwriters to administer such offering, who shall be reasonably
satisfactory to the Company.
(c) DEMAND EXPENSES. Subject to the limitations set forth in
Section 1.3(d) hereof, the Investor shall pay for all Registration Expenses
relating to the Demand Registration.
(d) LIMITATIONS ON DEMAND RIGHTS. The Investor may only
request two Demand Registrations. However, in addition to such two Demand
Registrations, the Investor may make four other Demand Registrations that
involve the use of Form S-3 or such other equivalent "short-form" registration
form then in use. A registration will not count as one of the permitted Demand
Registrations until the registration statement relating thereto has become
effective.
1.3 PROCEDURE. With respect to any Piggyback Registration or
Demand Registration, the Company shall use its best efforts to effect the
registration of all the Piggyback Registrable Securities or Demand Registrable
Securities, as the case may be (collectively, the "Request Securities"), which
the Investor has requested to be included therein, as quickly as practicable. In
connection with any such request, the Company shall do the following as
expeditiously as possible:
(i) prepare and file with the SEC a registration statement on
any form for which the Company then qualifies and which is available for the
registration of the Request Securities;
(ii) include in the registration on such form all the Request
Securities and use its reasonable efforts to cause such registration statement
to become effective; PROVIDED, HOWEVER, that at least two days before filing
such registration statement or any prospectus or any amendment or supplement
thereto, including documents to be incorporated be reference upon or after the
initial filing of such registration statement, the Company shall furnish to the
Investor copies of all such documents proposed to be filed (including documents
to be incorporated by reference therein), which documents will be subject to
reasonable review and comments of the Investor;
(iii) unless the Company qualifies to use a Form S-3
registration statement or any similar form then in effect, prepare and file with
the SEC such amendments and post-effective amendments and supplements to the
registration statement or any prospectus as may be necessary to keep the
registration statement effective for a period of not more than 180 days and
comply with the provisions of the Securities Act applicable to the Company with
respect to the disposition of all the Request Securities, covered by such
registration statement or any supplement to any such prospectus;
(iv) if the Company qualifies to use a Form S-3 registration
statement or any similar form then in effect and if the Company receives a
request for a Demand Registration, prepare and file with the SEC such
registration statement to permit the offering of the Demand Registrable
Securities to be made on a continuous basis pursuant to Rule 415 (or any similar
rule that may be adopted by the SEC) under the Securities Act (a "Shelf
Registration") and keep the Shelf Registration current and continuously
effective until 12 months from the effective date of the Shelf Registration.
(v) furnish to the Investor, such number of copies of such
registration statement, each amendment and supplement thereto, the prospectus
included in such registration statement and such other documents as the Investor
may reasonably request;
(vi) use its best efforts to register or qualify such Request
Securities under such other securities or blue sky laws of such jurisdiction as
the Investor reasonably requests and do any and all other acts and things which
may be reasonably necessary or advisable to enable the Investor to consummate
the disposition in such jurisdiction (provided that the Company will not be
required to (i) qualify generally to do business in any jurisdiction where it
would not otherwise be required to qualify but for this subparagraph, (ii)
subject itself to taxation in any such jurisdiction or (iii) consent to general
service of process in any such jurisdiction);
(vii) notify the Investor at any time when a prospectus
relating thereto is required to be delivered under the Securities Act, of the
happening of any event as a result of which the prospectus included in such
registration statement contains an untrue statement of material fact or omits
any fact necessary to make the statements therein in light of the circumstances
under which they were made, not misleading, and, at the request of the Investor,
the Company will, at the Investor's own expense, prepare a supplement or
amendment to such prospectus so that, as thereafter delivered to subsequent
purchasers of such Request Securities, such prospectus will not contain an
untrue statement of a material fact or omit to state any fact necessary to make
the statements therein, in light of the circumstances under which they were
made, not misleading;
(viii) cause all such Request Securities, to be listed on
each securities exchange or system on which similar securities issued by the
Company are then listed;
(ix) provide a transfer agent and registrar for all such
Request Securities, not later than the effective date of such registration
statement;
(x) enter into such customary agreements (including
underwriting agreements in customary form for transactions of comparable size
and terms) and take all such other actions as the Investor or the underwriters,
if any, reasonably request in order to expedite or facilitate the disposition of
such Request Securities, (including, without limitation, effecting a stock split
or a combination of shares);
(xi) make available for inspection by any underwriter
participating in any distribution pursuant to such registration statement and
any attorney, accountant or other agent retained by the underwriter (together
the "Agents"), all financial and other records, pertinent corporate documents
and properties of the Company (collectively, the "Records") to the extent
reasonably necessary to enable such person to exercise their due diligence
responsibilities and cause the Company's officers, directors, employees and
independent accountants to supply all information reasonably requested by any
such seller, underwriter, attorney, accountant or agent in connection with such
registration statement;
(xii) in the event of the issuance of any stop order
suspending the effectiveness of a registration statement, or of any order
suspending or preventing the use of any related prospectus or suspending the
qualification of any securities included in such registration statement for sale
in any jurisdiction, use its reasonable efforts promptly to obtain the
withdrawal of such order;
(xiii) use its reasonable efforts to obtain a "cold comfort"
letter from the independent public accountants of the Company which is addressed
to the Investor and any underwriters and contains such matters of the type
customarily covered by "cold comfort" letters; and
(xiv) use its reasonable efforts to obtain an opinion from
counsel for the Company which is addressed to the Investor and underwriter and
contains such matters of the type customarily covered by counsel for the issuer
of securities.
(a) AFFIDAVITS OF THE INVESTOR. With respect to any Piggyback
Registration or Demand Registration, the Investor shall furnish to the Company
in writing such information and affidavits as the Company reasonably requests
for use in connection with the registration of the Request Securities.
(b) PUBLIC SALE BY THE INVESTOR. The Investor shall not effect
any public sale or distribution of Request Securities, of any class or series
being registered in a Demand Registration or Piggyback Registration for offering
to the public, any security issued by the issuer of such class or series or any
security exchangeable or exercisable for or convertible into any such class or
series of any such Request Securities or any such similar security, including a
sale pursuant to Rule 144 (or any similar rule then in force) under the
Securities Act, during, in the case of a Piggyback Registration, the 14 days
prior to, and during the 180 day period beginning on, the effective date of the
Piggyback Registration (except as part of such registration or pursuant to
registrations on Form S-4 or S-8 or any successor form to either such form) and,
in the case of any Demand Registration, the period commencing on the date of
filing the Demand Registration and ending on the 180th day following the
effective date of the Demand Registration (except as part of such Demand
Registration).
(c) PUBLIC SALE BY THE COMPANY AND OTHERS. Neither the Company
nor any of its Affiliates (other than the Investor, if deemed to be an
Affiliate) will effect any public sale or distribution of any securities of any
class or series being registered in a Piggyback Registration or Demand
Registration for offering to the public, any similar security issued by the
issuer of such class or series or any security convertible into or exchangeable
or exercisable for any such security during, in the case of a Piggyback
Registration, the 14 days prior to, and during the 180 day period beginning on,
the effective date of the Piggyback Registration (except as part of such
registration or pursuant to registrations on Form S-4 or S-8 or any successor
form to either such form) and, in the case of any Demand Registration, the
period commencing on the date of filing the Demand Registration and ending on
the 180th day following the effective date of the Demand Registration.
"Affiliate" shall mean, with respect to any specified Person (as defined in
Section 1.4), any other Person that directly, or indirectly through one or more
intermediaries, controls, is controlled by, or is under common control with,
such specified Person.
(d) REGISTRATION EXPENSES. The Investor shall pay for the
Company's out-of-pocket costs and out-of-pocket expenses ("Registration
Expenses") of each registration hereunder, including the following: (i)
registration and filing fees with respect to the Request Securities, (ii)
reasonable fees and disbursements of counsel in connection with blue sky
qualifications with respect to the Request Securities, (iii) expenses incident
to the preparation, printing and filing of the registration statement, each
preliminary prospectus and definitive prospectus and each amendment or
supplement to any of the foregoing and copies thereof with respect to the
Request Securities, (iv) underwriting fees, discounts or commissions
attributable to the sale of Request Securities, as the case may be, by the
Investor, (v) fees and expenses incurred in connection with the listing of the
Request Securities, (vi) fees and disbursements of counsel for the Company and
fees and expenses of independent certified public accountants retained by the
Company with respect to the Request Securities, and (vii) fees and expenses
associated with any filings with or submission to the NASD with respect to the
Request Securities. Notwithstanding the foregoing, the Investor shall not have
any obligation to pay any internal costs and expenses (including, without
limitation, all salaries and expenses of officers and employees of the Company
performing legal or accounting duties) or any costs and expenses to the extent
that (x) such costs and expenses would have been incurred by the Company absent
such registration hereunder or (y) another party is contractually obligated to
pay such costs and expenses.
1.4 INDEMNIFICATION REGARDING REGISTRATION RIGHTS.
(a) INDEMNIFICATION BY THE COMPANY. The Company shall
indemnify the Investor and, if applicable, its officers and directors and each
person or entity (a "Person") who controls the Investor (within the meaning of
the Securities Act) against all losses, claims, damages, liabilities and
expenses, including reasonable attorneys' fees and disbursements and expenses of
investigation, incurred by such party pursuant to any actual or threatened
action, suit, proceeding or investigation, or to which any of the foregoing
Persons may become subject under the Securities Act, the Securities Exchange Act
of 1934, as amended (the "Exchange Act"), or other federal or state laws,
insofar as such losses, claims, damages, liabilities and expenses arise out of
or are caused by any untrue or alleged untrue statement of material fact
contained in any registration statement, preliminary prospectus or definitive
prospectus or any amendment thereof or supplement thereto or any omission or
alleged omission of a material fact required to be stated therein or necessary
to make the statements therein not misleading, except insofar as the same are
caused by or contained in any information furnished in writing to the Company by
the Investor specifically for use in the preparation thereof or by the
Investor's failure, if required, to deliver a copy of the registration statement
or prospectus or any amendments or supplements thereto after the Company has
furnished the Investor with copies of the same pursuant to Section 1.3(v).
(b) INDEMNIFICATION BY THE INVESTOR. In connection with any
registration statement in which the Investor is participating, the Investor
shall indemnify the Company, its directors and officers and each Person who
controls the Company (within the meaning of the Securities Act) against any
losses, claims, damages, liabilities and expenses, including reasonable
attorneys' fees and disbursements and expenses of investigation, incurred by
such party pursuant to any actual or threatened action, suit, proceeding or
investigation, or to which any of the foregoing Persons may become subject under
the Securities Act, the Exchange Act or other federal or state laws, insofar as
such losses, claims, damages, liabilities and expenses arise out of or are
caused by any untrue or alleged untrue statement of material fact contained in
the registration statement, preliminary prospectus or definitive prospectus or
any amendment thereof or supplement thereto or any omission or alleged omission
of a material fact required to be stated therein or necessary to make the
statements therein not misleading, but only to the extent that such untrue
statement or omission is contained in information furnished, in writing, by the
Investor to the Company specifically for use in the preparation of such
registration statement or prospectus. The amount of any indemnity under this
Section 1.4(b) shall not exceed the gross proceeds received by the Investor from
the applicable offering.
(c) PROCEDURE. Any Person entitled to indemnification hereunder will
(i) give prompt written notice to the indemnifying party of any claim with
respect to which it seeks indemnification, provided that the failure of any
indemnified party to give notice shall not relieve the indemnifying party of its
obligations hereunder except to the extent the indemnifying party is actually
prejudiced by such failure and (ii) unless in such indemnified party's
reasonable judgment a conflict of interest between such indemnified and
indemnifying parties may exist with respect to such claim, permit such
indemnifying party to assume the defense of such claim with counsel reasonably
satisfactory to the indemnified party. If such defense is assumed, the
indemnifying party will not be subject to any liability for any settlement made
by the indemnified party without its consent (but such consent will not be
unreasonably withheld). An indemnifying party who is not entitled to, or elects
not to assume the defense of a claim will not be obligated to pay the fees and
expenses of more than one counsel for all parties indemnified by such
indemnifying party with respect to such claim, unless in the reasonable judgment
of any indemnified party a conflict of interest may exist between such
indemnified party and any other of such indemnified parties with respect to such
claim.
(d) SURVIVAL. The indemnification provided for under this Agreement
will remain in full force and effect regardless of any investigation made by or
on behalf of the indemnified party or any officer, director or controlling
Person of such indemnified party and will survive the transfer of securities.
(e) CONTRIBUTION. If the indemnification provided for in this Section
1.4 from the indemnifying party is unavailable to the indemnified party, then
the indemnifying party, instead of indemnifying the indemnified party, shall
contribute to and pay the amount paid or payable by such indemnified party as a
result of the loss, claim, damage, liability or expenses (collectively, the
"Claim") giving rise to indemnification hereunder in such proportion as is
appropriate to reflect the relative fault of the indemnifying and indemnified
party in connection with the actions which gave rise to the Claim. The relative
fault of the indemnifying party and the indemnified party shall be determined by
reference to, among other things, whether the action in question has been made
by, or relates to, information supplied by such indemnifying party or
indemnified party, and the parties' relevant intent, knowledge, access to
information and opportunity to correct or prevent such action. The Company and
the Investor agree that it would not be just and equitable if contribution and
payment pursuant to this Section 1.4 were determined by pro rata allocation or
by any other allocation method which does not take into account the equitable
considerations referred to in the preceding sentence. The amount paid or payable
as a result of a Claim shall include any legal or other fees and expenses
reasonably incurred by such party in connection with such Claim. However, no
Person guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) shall be entitled to contributions and payment from
any Person who was not guilty of such fraudulent misrepresentation.
1.5 PARTICIPATION IN UNDERWRITTEN REGISTRATIONS. No Person may
participate in any underwritten registration hereunder unless such Person (a)
agrees to sell its securities on the basis provided in any underwriting
arrangements reasonably approved by the Persons entitled hereunder to approve
such arrangements and (b) accurately completes and executes all questionnaires,
powers of attorney, indemnities, underwriting agreements and other documents
customarily required under the terms of such underwriting arrangements.
1.6 RULE 144. The Company shall file, on a timely basis, any reports
required to be filed by it under the Securities Act and the Exchange Act (and if
the Company is not required to file reports pursuant to the Exchange Act, the
Company shall, upon the request of the Investor, make publicly available the
information specified in subparagraph (c)(2) of Rule 144 of the Securities Act)
so as to enable the Investor to sell the Piggyback Registrable Securities and
Demand Registrable Securities without registration under the Securities Act
within the limitation of the exemptions provided by (a) Rule 144 under the
Securities Act, as such Rule may be amended from time to time or (b) any similar
rule adopted by the SEC.
1.7 TRANSFER OF REGISTRATION RIGHTS. Rights with respect to Piggyback
Registrable Securities and Demand Registrable Securities may be transferred by
the Investor (or any subsequent transferee pursuant to this Section 1.7) to any
Person in connection with the transfer of Piggyback Registrable Securities and
Demand Registrable Securities to such Person, in all cases, if (a) any such
transferee shall have executed and delivered to the Secretary of the Company a
properly completed agreement substantially in the form of EXHIBIT 1.7, (b) the
transferor shall have delivered to the Secretary of the Company, no later than
15 days following the date of the transfer, written notification of such
transfer setting forth the name of the transferor, name and address of the
transferee, and the number of Piggyback Registrable Securities and Demand
Registrable Securities which shall have been so transferred and (c) the number
of Piggyback Registrable Securities and Demand Registrable Securities, as the
case may be, which shall have been so transferred is equal to or exceeds 50% of
the total number of the Piggyback Registrable Securities and Demand Registrable
Securities, as the case may be.
1.8 MERGERS, CONSOLIDATIONS, ETC. The Company shall not, directly or
indirectly enter into any merger, consolidation or reorganization in which the
Company shall not be the surviving corporation, unless prior to such merger,
consolidation or reorganization, the surviving corporation shall have agreed in
writing to assume the obligations of the Company under this Agreement, and for
that purpose references hereunder to "Piggyback Registrable Securities" and
"Demand Registrable Securities" shall be deemed to include the securities which
the holders of Piggyback Registrable Securities and Demand Registrable
Securities would be entitled to receive in exchange for such securities pursuant
to any such merger, consolidation or reorganization.
ARTICLE II
MISCELLANEOUS
2.1 AMENDMENT AND CERTAIN WAIVERS. This Agreement may be amended or
modified only by a written agreement executed by all parties to this Agreement.
2.2 BENEFIT OF PARTIES; ASSIGNABILITY. All of the terms and conditions
of this Agreement shall be binding upon and inure to the benefit of the parties
and their respective successors and permitted assigns. This Agreement may not be
assigned, in whole or in part, by either party without the prior written consent
of the other party, except (a) pursuant to Section 1.7 hereof and (b) that the
Investor may assign this Agreement in whole to an Affiliate of the Investor
without the necessity for securing prior written consent of the Company.
2.3 SEVERABILITY. If any court or any governmental authority or agency
declares all or any part of any Section of this Agreement to be unlawful or
invalid, such unlawfulness or invalidity shall not serve to invalidate any other
Section of this Agreement, and if only a portion of any Section is so declared
to be unlawful or invalid, such unlawfulness or invalidity shall not serve to
invalidate the balance of such Section.
2.4 NOTICES. All notices, requests, claims, demands and other
communications hereunder shall be in writing and shall be given or made (and
shall be deemed to have been duly given or made) upon the earliest to occur of
(a) receipt, if made by personal service, (b) three business days after
dispatch, if made by reputable overnight courier service or (c) upon the
delivering party's receipt of a written confirmation of a transmission made by
telecopy to the respective parties at the following addresses (or at such other
address for a party as shall be specified in a notice given in accordance with
this Section 2.4):
If to the Company:
InnoServ Technologies, Inc.
320 Westway, Suite 520
Arlington, Texas 76018
Telecopy No.: 817-472-2926
Attn: Michael Puls
With a copy to:
Gibson, Dunn & Crutcher LLP
1717 Main Street, Suite 5400
Dallas, Texas 75201
Telecopy No.: 214-698-3400
Attn: Stephen C. Johnson
If to Parent or Sub:
General Electric Company
c/o GE Medical Systems
3000 North Grandview Boulevard
Waukesha, Wisconsin 53188
Telecopy No.: 414-544-3573
Attn: General Counsel
2.5 GOVERNING LAW. The validity, meaning and effect of this Agreement
shall be determined in accordance with the laws of the State of New York
applicable to contracts made and to be performed in that state.
2.6 COUNTERPARTS. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original but all of which shall
together constitute one and the same document.
2.7 HEADINGS. The headings used herein are solely for the convenience
of the parties and shall not constitute a part hereof or serve to modify or
interpret the text of this Agreement.
2.8 ENTIRE AGREEMENT. This Agreement, together with the Merger
Agreement, constitute and encompass the entire agreement and understanding of
the parties hereto with regard to the transactions contemplated or provided for
herein or therein.
2.9 EXPENSES. Each party shall bear and pay its own expenses incurred
in connection with negotiating and preparing this Agreement.
<PAGE>
EXHIBIT 1.7
AGREEMENT TO BE BOUND
BY THE REGISTRATION RIGHTS PROVISIONS
OF STOCK PURCHASE AGREEMENT
The undersigned, being the transferee of ________________ shares of the
__________________ stock, $_________ par value per share (the "Registrable
Securities"), of INNOSERV TECHNOLOGIES, INC., a California corporation (the
"Company"), as a condition to the receipt of such Registrable Securities,
acknowledges that matters pertaining to the registration of such Registrable
Securities are governed by Article I of the Registration Rights Agreement dated
as of May_____, 1998 initially among the Company and the Investor referred to
therein (the "Agreement"), and the undersigned hereby (1) acknowledges receipt
of a copy of the Agreement, and (2) agrees to be bound by the terms of the
Agreement, as the same has been or may be amended from time to time.
Agreed to this __ day of ______________________, _________________.
[Name]
[Address]
EXHIBIT 99(D)
SHAREHOLDERS AGREEMENT
SHAREHOLDERS AGREEMENT, dated as of May 19, 1998, by and among General
Electric Company, a New York corporation acting through its GE Medical Systems
division ("Parent"), on the one hand, and the persons set forth in the signature
page hereto in their capacities as shareholders of InnoServ Technologies, Inc.,
a California corporation (the "Company") (collectively, the "Shareholders" and
individually, a "Shareholder"), on the other hand.
WHEREAS, concurrently herewith, Parent, a subsidiary of a subsidiary of
Parent and the Company are entering into an Agreement and Plan of Merger (the
"Merger Agreement"; capitalized terms used without definition herein having the
meanings ascribed thereto in the Merger Agreement);
WHEREAS, each Shareholder has sole, or together with such Shareholder's
spouse as necessary, has complete voting and dispositive power and/or full
voting power as to the aggregate number of shares of Common Stock, par value
$.01 per share, of the Company (the "Company Common Stock") set opposite such
Shareholder's name on SCHEDULE I attached hereto, whether as certificated shares
in the name of such Shareholder or held in brokerage accounts in the name of
such Shareholder; such shares of Company Common Stock, as such shares may be
adjusted by any stock dividend, stock split, recapitalization, combination or
exchange of shares, merger, consolidation, reorganization or other change or
transaction of or by the Company, being referred to herein as the "Shares";
WHEREAS, approval of the Merger Agreement by the Company's
shareholders is a condition to the consummation of the Merger;
WHEREAS, as a condition to its entering into the Merger Agreement,
Parent has required that the Shareholders agree, and the Shareholders have
agreed, to enter into this Agreement;
WHEREAS, the Shareholders have been informed that the Board of
Directors of the Company has approved the Merger Agreement.
NOW, THEREFORE, in consideration of the foregoing and the mutual
covenants and agreements set forth herein, the parties hereto agree as follows:
Section 1. AGREEMENT TO VOTE, RESTRICTIONS ON DISPOSITIONS, ETC.
During the term of the Agreement:
a. Each of the Shareholders hereby agrees to attend the
Company Meeting, in person or by proxy, and to vote (or cause to be
voted) all Shares, and any other voting securities of the Company,
whether issued heretofore or hereafter, that such person owns or has
the right to vote, for approval and adoption of the Merger Agreement
and the Merger, such agreement to vote to apply also to any adjournment
or adjournments of the Company Meeting. Each Shareholder agrees not to
grant any proxies or enter into any voting agreement or arrangement
inconsistent with this Agreement.
b. Each of the Shareholders hereby agrees to vote (or cause to
be voted) all Shares, and any other voting securities of the Company,
whether issued heretofore or hereafter, that such person owns or has
the right to vote, against (i) any merger (other than the Merger),
consolidation, combination, sale of assets, reorganization,
recapitalization, dissolution, liquidation or other business
combination or similar transaction involving the Company or its
Subsidiaries, securities or assets (including any Business Combination
Proposal) which is not approved in writing by Parent or (ii) any
amendment of the Company's articles of incorporation or by-laws or
other proposal involving the Company or any Subsidiary, which amendment
or proposal would in any manner impede, frustrate, prevent or nullify
the Merger, the Merger Agreement or any of the transactions
contemplated by the Merger Agreement or which could result in any of
the conditions to the Company's obligations under the Merger Agreement
not being fulfilled.
c. Each of the Shareholders hereby agrees that, without the
prior written consent of Parent, such Shareholder shall not, directly
or indirectly, sell, offer to sell, grant any option for the sale of or
otherwise, pledge, transfer, tender or dispose of, or enter into any
agreement to sell, pledge (other than existing margin call pledge
agreements with respect to Shares held in brokerage accounts in the
name of a Shareholder), transfer, tender or dispose of, any Shares and
any other voting securities of the Company, issued heretofore or
hereinafter that such person owns or has the right to vote; PROVIDED,
HOWEVER, that Parent shall consent to any such sale, pledge, transfer
or disposition of any such Shares or other voting securities by and
between Shareholders.
d. Each of the Shareholders, solely in his capacity as a
shareholder, hereby agrees not to directly or indirectly take (nor
shall such Shareholder authorize or permit any representative,
investment banker, financial advisor, attorney, accountant or other
agent of such Shareholder to take) any action to (i) encourage, solicit
or initiate the submission of any Business Combination Proposal or (ii)
participate in any way in discussions or negotiations with, or furnish
any non-public written information to, any person in connection with,
or take any other action to encourage the making of any proposal that
constitutes, or may reasonably be expected to lead to, any Business
Combination Proposal; ; provided, that with respect to Shareholders who
serve as officers or directors of the Company, such Shareholders acting
solely in their capacity as officers or directors may (i) participate
in discussions or negotiations with or furnish information to any Third
Party that makes an unsolicited Business Combination Proposal that the
Board of Directors of the Company determines (after consultation with
its financial advisors) may reasonably be expected to result in a
Superior Proposal, and permit the Company to enter into any
confidentiality agreement or standstill agreement with such Third Party
in connection with such a Business Combination Proposal, (ii) take all
steps necessary to cause the Company to comply with Rule 14e-2
promulgated under the Exchange Act with regard to any Business
Combination Proposal (assuming that such Business Combination Proposal
includes a tender offer requiring the Company's response pursuant to
such Rule), (iii) take the steps necessary as directors to fail to make
or withdraw or modify the Board of Directors' recommendation referred
to in SECTION 8.2 of the Merger Agreement if there exists a Business
Combination Proposal that is a Superior Proposal or if such director
determines, in good faith and after consultation with independent
counsel, that such action is required to discharge properly his
fiduciary duties, or (iv) if the Company terminates the Merger
Agreement in accordance with Section 10.1(e) thereof, cause the Company
to enter into an agreement with respect to or recommend to its
shareholders a Business Combination Proposal that is a Superior
Proposal.
e. Each of the Shareholders agrees to promptly notify Parent
in writing of the nature and amount of any acquisition by such
Shareholder of any voting securities of the Company acquired by such
Shareholder hereinafter.
Section 2. REPRESENTATIONS AND WARRANTIES OF THE SHAREHOLDERS. Each of
the Shareholders, as to himself, herself or itself, as an individual
shareholder, represents and warrants to Parent as follows: (a) this Agreement
has been duly executed and delivered by such Shareholder; (b) assuming the due
authorization, execution and delivery of this Agreement by Parent, this
Agreement constitutes the valid and binding agreement of such Shareholder
enforceable against such Shareholder in accordance with its terms, except as may
be limited by applicable bankruptcy, insolvency, reorganization, moratorium and
other similar laws of general application which may affect the enforcement of
creditors' rights generally and by general equitable principles; (c) the shares
of Company Common Stock listed next to the name of such Shareholder on SCHEDULE
I hereto are the only voting securities of the Company owned (beneficially or of
record) by such Shareholder and are held by such Shareholder either as
certificated shares or in brokerage accounts in the name of such Shareholder
free and clear of all liens, charges, encumbrances, restrictions and commitments
of any kind; and (d) the execution and delivery of this Agreement by such
Shareholder does not conflict with any agreement, order or other instrument
binding upon such Shareholder, nor requires any regulatory filing or approval.
Section 3. FURTHER ASSURANCES. Each party shall execute and deliver
such additional instruments and other documents and shall take such further
actions as may be necessary or appropriate to effectuate, carry out and comply
with all of their obligations under this Agreement. Without limiting the
generality of the foregoing, none of the parties hereto shall enter into any
agreement or arrangement (or alter, amend or terminate any existing agreement or
arrangement) if such action would materially impair the ability of any party to
effectuate, carry out or comply with all the terms of this Agreement.
Section 4. REPRESENTATIONS AND WARRANTIES OF PARENT. Parent represents
and warrants to each Shareholder as follows: (a) each of this Agreement and the
Merger Agreement has been duly executed and delivered by a duly authorized
officer or employee of Parent; and (b) assuming the due authorization, execution
and delivery of this Agreement by the Company and the Shareholders, each of this
Agreement and the Merger Agreement constitutes a valid and binding agreement of
Parent, enforceable against Parent in accordance with its terms, except as may
be limited by applicable bankruptcy, insolvency, reorganization, moratorium and
other similar laws of general application which may affect the enforcement of
creditors' rights generally and by general equitable principles.
Section 5. EFFECTIVENESS AND TERMINATION. It is a condition precedent
to the effectiveness of this Agreement that the Merger Agreement shall have been
executed and delivered and be in full force and effect. This Agreement shall
terminate upon the earliest of (i) the close of business on September 30, 1998,
(ii) the Effective Date or (iii) the termination of the Merger Agreement in
accordance with its terms; PROVIDED, that if any Business Combination Proposal
shall have been made prior to the termination of the Agreement and the Merger
Agreement is terminated pursuant to Sections 10.1(b)(ii) or (c)(ii) of the
Merger Agreement, Sections 1(b), (c) and (d) hereof shall survive for 180 days
after termination of this Agreement. Upon any such termination of this
Agreement, except for any rights any party may have in respect of any breach by
any other party of its or his obligations hereunder, none of the parties hereto
shall have any further obligation or liability hereunder.
Section 6. MISCELLANEOUS.
a. NOTICES, ETC. All notices, requests, demands or other
communications required by or otherwise with respect to this Agreement
shall be in writing and shall be deemed to have been duly given to any
party when delivered personally (by courier service or otherwise), or
seven days after being mailed by first-class mail, postage prepaid in
each case to the applicable addresses set forth below:
If to Parent: GE Medical Systems
3000 North Grandview Boulevard
Waukesha, Wisconsin 53188
Attention: J. Keith Morgan
with a copy to: Sidley & Austin
One First National Plaza
Chicago, Illinois 60603
Attention: Dennis V. Osimitz
If to any of the Shareholders: to the addresses set forth on SCHEDULE I:
with a copy to: Gibson, Dunn & Crutcher LLP
1717 Main Street
Dallas, Texas 75201-7390
Attention: Stephen C. Johnson
and with an additional copy to: InnoServ Technologies, Inc.
320 Westway, Suite 520
Arlington, TX 76018
Attn: Michael Puls
or to such other address as such party shall have designated by notice
so given to each other party.
b. AMENDMENTS, WAIVERS, ETC. This Agreement may not be
amended, changed, supplemented, waived or otherwise modified or
terminated except by an instrument in writing signed by Parent, the
Company and the Shareholders affected thereby; PROVIDED that: without
the consent of any party no such amendment, change, supplement, waiver,
modification or termination shall in any way further restrict the
transferability of any Company Common Stock held by such party, impose
any obligation on such party, diminish the benefits of such party
hereunder or restrict the rights of such party as set forth herein),
without the consent of such party.
c. SUCCESSORS AND ASSIGNS. This Agreement shall be binding
upon and shall inure to the benefit of and be enforceable by the
parties and their respective successors and assigns, including without
limitation any trustee, executor, heir, legatee or personal
representative succeeding to the ownership or voting power of such
Shareholder's shares of Company Common Stock or other securities
subject to this Agreement. Notwithstanding any transfer of shares of
Company Common Stock, the transferor shall remain liable for the
performance of all obligations under this Agreement of such transferor.
d. ENTIRE AGREEMENT. This Agreement (together with the Merger
Agreement) embodies the entire agreement and understanding among the
parties relating to the subject matter hereof and supersedes all prior
agreements and understandings relating to such subject matter. There
are no representations, warranties or covenants by the parties hereto
relating to such subject matter other than those expressly set forth in
this Agreement and the Merger Agreement.
e. SEVERABILITY. If any term of this Agreement or the
application thereof to any party or circumstance shall be held invalid
or unenforceable to any extent, the remainder of this Agreement and the
application of such term to the other parties or circumstances shall
not be affected thereby and shall be enforced to the greatest extent
permitted by applicable law, PROVIDED that in such event the parties
shall negotiate in good faith in an attempt to agree to another
provision (in lieu of the term or application held to be invalid or
unenforceable) that will be valid and enforceable and will carry out
the parties' intentions hereunder.
f. SPECIFIC PERFORMANCE. The parties acknowledge that money
damages are not an adequate remedy for violations of this Agreement and
that any party may, in its sole discretion, apply to a court of
competent jurisdiction for specific performance or injunction or such
other relief as such court may deem just and proper in order to enforce
this Agreement or prevent any violation hereof and, to the extent
permitted by applicable law, each party waives any objection to the
imposition of such relief.
g. REMEDIES CUMULATIVE. All rights, powers and remedies
provided under this Agreement or otherwise available in respect hereof
at law or in equity shall be cumulative and not alternative, and the
exercise or beginning of the exercise of any thereof by any party shall
not preclude the simultaneous or later exercise of any other such
rights, power or remedy by such party.
h. NO WAIVER. The failure of any party hereto to exercise any
right, power or remedy provided under this Agreement or otherwise
available in respect hereof at law or in equity, or to insist upon
compliance by any other party hereto with its obligations hereunder,
and any custom or practice of the parties at variance with the terms
hereof, shall not constitute a waiver by such party of its right to
exercise any such or other right, power or remedy or to demand such
compliance.
i. NO THIRD PARTY BENEFICIARIES. This Agreement is not
intended to be for the benefit of and shall not be enforceable by any
person or entity who or which is not a party hereto.
j. JURISDICTION. Each party hereby irrevocably submits to the
exclusive jurisdiction of the Circuit Court in the State of New York or
the United States District Court for the Southern District of New York
or any court of the State of New York located in the City of New York
in any action, suit or proceeding arising in connection with this
Agreement, and agrees that any such action, suit or proceeding shall be
brought only in such court (and waives any objection based on FORUM NON
CONVENIENS or any other objection to venue therein). Each party hereto
waives any right to a trial by jury in connection with any such action,
suit or proceeding.
k. GOVERNING LAW. This Agreement and all disputes hereunder
shall be governed by and construed and enforced in accordance with the
California General Corporation Law to the fullest extent possible and
in the absence of applicability of the aforementioned California
General Corporation law, by the internal laws of the State of New York
without regard to principles of conflicts of law.
l. NAME, CAPTIONS, GENDER. The name assigned this Agreement
and the section captions used herein are for convenience of reference
only and shall not affect the interpretation or construction hereof.
Whenever the context may require, any pronoun used herein shall include
the corresponding masculine, feminine or neuter forms.
m. COUNTERPARTS. This Agreement may be executed in any number
of counterparts, each of which shall be deemed to be an original, but
all of which together shall constitute one instrument. Each counterpart
may consist of a number of copies each signed by less than all, but
together signed by all, the parties hereto.
n. LIMITATION ON LIABILITY. No Shareholder shall have any
liability hereunder for any actions or omissions of any other
Shareholder.
o. EXPENSES. Except as otherwise provided in the Merger
Agreement, each party shall bear its own expenses incurred in
connection with this Agreement and the transactions contemplated
hereby, except that in the event of a dispute concerning the terms or
enforcement of this Agreement, the prevailing party in any such dispute
shall be entitled to reimbursement of reasonable legal fees and
disbursements from the other party or parties to such dispute.
p. SHAREHOLDER CAPACITY. Each Shareholder signs this Agreement
solely in his capacity as the record holder and/or beneficial owner of
the Shares set opposite his name on SCHEDULE I and nothing herein shall
limit, impose any obligation on, or affect any actions taken by such
Shareholder, as applicable, serving in his capacity as an officer or
director of the Company, including without limitation, any actions
taken by such Shareholder in the fulfillment of his fiduciary duties in
his capacity as an officer or director of the Company. For the purposes
of this Agreement, all actions taken by a Shareholder acting in his
capacity as an officer or director of the Company shall be viewed as if
taken by a person separate and apart from such Shareholder, without
consideration to such person's ownership of equity interests in the
Company
<PAGE>
SCHEDULE I
NAME AND ADDRESS
OF SHAREHOLDER NUMBER OF SHARES % OUTSTANDING
-------------- ---------------- -------------
Dudley A. Rauch 962,399 31.98
Cecila B. Rauch 52,868 1.76
The Rauch Family Foundation 13,743 .46
Henry B Rauch Trust 26,322 .87
The Moehring Charitable Remainder 102,548 3.41
Trust
Michael M. Sachs 65,587 2.18
Westrec Rollover P/S Plan 52,755 1.75
Dr. Samuel Salen IRRA 70,000 2.33
The Salen Family 1995 Revocable 121,962 4.05
Living Trust
MSB Radiology Medical Group, Inc. 89,095 2.96
Profit Sharing Trust
MSB Radiology Medical Group, Inc. 11,000 .37
Bernard J. Korman 21,000 .70
TOTAL 1,589,279 52.82
EXHIBIT 99(e)
POWER OF ATTORNEY
KNOWN ALL MEN BY THESE PRESENTS that General Electric Company ("GE")
constitutes and appoints each of Robert E. Healing and Eliza W. Fraser as its
true and lawful attorney-in-fact and agent with full power of substitution and
resubstitution, for and on behalf of GE and in GE's respective name, place and
stead, in any and all capacities, to sign any Statements on Schedule 13D,
Schedule 14D, Form 3, Form 4 or Form 5 under the Securities Exchange Act of
1934, and any and all amendments to any thereof and other documents in
connection therewith (including, without limitation, any joint filing
agreement with respect to any Statement on Schedule 13D or 14D or amendment
thereto) and to file the same, with all exhibits thereto, with the Securities
and Exchange Commission, granting unto each said attorney-in-fact and agent
full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the premises, as fully and to
all intents and purposes as GE might or could do in person, hereby ratifying
and confirming all that each said attorney-in-fact and agent, or his or her
substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.
Dated: July 31, 1997
GENERAL ELECTRIC COMPANY
By: /s/ B.W. Heineman, Jr.
------------------------------------
Name: B.W. Heineman, Jr.
Title: Senior Vice President,
General Counsel and Secretary
